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1. Introduction 
The oxidative hypothesis of atherosclerosis states that peroxide modification of LDL (or other 
lipoproteins) is important and probably required for the pathogenesis of arterial sclerotic 
disease; thus, there is an assumption that inhibition of LDL oxidation would increase or 
prevent atherosclerosis and its clinical consequences [1]. It is believed that the basis for the 
atherosclerotic plaque development is the foam cell formation from oxidized low-density 
lipoproteins (LDL) captured by monocytes and macrophages via scavenger-receptors. 
Oxidation of LDL is also important for the healthy vessel functioning. High LDL 
concentrations can suppress the function of arteries in relation to release of nitric oxide from 
the endothelium, and many of such effects are mediated by the products of lipid oxidation 
[2]. Moreover, oxidized LDL inhibit the endothelium-dependent nitric oxide mediated 
relaxations in a rabbit isolated coronary arteries. Oxidized LDL induce apoptosis in the 
vascular cells, including macrophages, and this is prevented by nitric oxide [3]. 
One of the most important mechanisms of the inflammation proatherogenic effect is 
development of the systemic oxidative stress, and, as a consequence of proatherogenic 
abnormalities of the blood lipoprotein metabolism, there is appearance of antibodies to 
them, alterations of the main artery wall structure [4]. 
At the same time, on the one hand, a high atherogenicity of strongly oxidized LDL, 
especially tiny subfractions, has been confirmed; on the other hand, the oxidative stress is 
one of the causes of endothelial dysfunction. 
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Endothelium vascular wall cells are involved into the interaction with the pathogenic LDL 
[5]. While macrophages are being overloaded with esterified cholesterol, oxysterols and 
other biologically active substances, including powerful enzymes with a wide spectrum of 
action, a foam cell is formed from the macrophage. Yet so far to its apoptosis the foam cell 
secrets a wide complex of interleukins, enzymes, mediators. Many of them induce a local 
inflammatory process, destruction of the surrounding intercellular substance, damage of the 
fibrous structures and separate cells. 
Many factors are considered as the most important factors for atherosclerosis development 
risk. Among such factors an important role belongs to the so-called proatherogenic states, 
including chronic stress and metabolic syndrome (MS) [6]. The proatherogenic character of 
stress is connected, first of all, with the activation of free radical oxidation and hyperlipidemia 
development. One of the principal statements of all contemporary conceptions of the 
atherosclerosis pathogenesis is thought to be the destruction of the cell membrane structure, 
which universal damage factor is peroxide oxidation of lipids (POL) [7]. 
It is well-known that free-radical processes play the leading role in atherosclerosis 
pathogenesis. So the antioxidants using in correction of proatherogenic states is fully 
explicable especially when we speak about natural antioxidants. Thus, the investigation of 
their biological effects under stress and metabolic syndrome is of grate interest and may be a 
perspective direction of research. 
At the same time it is known that the enzymes associated with HDL, paraoxonase and PAF-
acetyl hydrolase can hydrolyse biologically active lipids of mm-LDL, destroy monocyte 
aggregates and decrease the endothelial activation of mm-LDL [8]. HDL also contain a high 
concentration of tocopherol due to which they can be free radical scavengers as well. 
Antioxidants protect LDL from peroxide oxidation and consequently from intensive uptake 
of LDL by macrophages decreasing the foam cell formation, the endothelium damage and 
possibility for lipids to infiltrate the intima. This condition supports the actuality of 
searching medicines for treating atherosclerosis, in which inhibition of the POL process 
plays an important part in the mechanism of their action [9]. Tocopherol, carotene, probucol, 
a number of plant medicines containing flavonoids are proposed as antioxidants.  
The overwhelming majority of antioxidant substances used in pharmacotherapy are 
xenobiotics and so substrates of CYP system actvating ROS formation. Moreover some of 
them, such as probucol, leade to HDL-C decreasing. 
Therefore, the substances of natural, in particular, plant origins that possess a complex 
activity draw attention of researchers. 
Phenolic compounds are widely present in the world of plants; they are the most 
widespread product of the plant metabolism. Participation of polyphenols in redox 
processes to produce stable quinone structures by their phenolic forms reveals an antiradical 
direction of their action which provides their direct antioxidant activity. At present it has 
been proven that polyphenols as antiradical agents not only hinder the initiation of free 
radical oxidation, but also interrupt the chain of lipoperoxidation [10]. A great variety of 
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studies carried out both in vitro and in vivo supports the ability of polyphenols to inactivate 
(“to bind”, “to scavenge”) the radicals that initiate chains of oxidation. First of all, it relates 
to the primary ROS - ·O2-and ·OH [11]. 
There are some data that such natural polyphenols as catechins and procyanidins exposed to 
the human blood plasma produce certain complexes primarily with ApoA-1, i.e. with HDL. 
One of the richest sources of polyphenols is Vitis vinifera and products of its processing, in 
particular wine. 
Phenolic substances of grapes, including flavonoids and other polyphenols of grape, wine 
and grape seeds, are of a great interest due to their antioxidant properties and the ability to 
scavenge free radicals [12]. 
Studies in vitro have shown that grape, wine and grape seeds inhibit the oxidation of LDL. 
The activity of those substances as oxidation inhibitors in wine diluted 1,000 times markedly 
exceeded the analogous values for vitamins C and E [13]. It has been experimentally proven 
that red wine polyphenols slow down LDL oxidation processes and prevent platelet 
aggregation, thus preventing coronary heart diseases [14]. 
However, there is not a lot of research in this field yet. Arguments for anti-atherogenic 
properties of antioxidants are not enough. Results of convincing research are needed in order 
to decisively recommend antioxidants for treatment and prophylaxis of atherosclerosis. 
2. Actuality 
Taking into account the leading role of the free-radical processes in atherosclerosis 
pathogenesis one can make a conclusion about expediency of using natural antioxidants in 
prophylaxis and correction of this disease. [15]. Consequently, the study of the antioxidant 
influence on the development of stress-reactions and metabolic syndrome (MS) with the 
purpose of prevention of harmful complications for the cardiovascular system is of 
undoubted interest.  
A number of studies also confirm the ability of a natural antioxidant α-tocopherol to reduce 
the risk of cardiovascular system diseases developed in patients with MS. It has been found 
that administration of α-tocopherol limits oxidation and cytotoxicity of LDL in the blood 
plasma significantly, supports the vascular endothelial function and reduces the intensity of 
systemic inflammation in the conditions of MS. The inhibiting effect of this antioxidant on 
aggregation and adhesion of platelets, adhesion of monocytes to endothelial cells and the 
smooth muscle cell proliferation has also been shown. However, numbers of experimental 
studies confirm that the single use of α-tocopherol is not enough for prevention of 
cardiovascular diseases in patients with MS [16]. It has been determined that the use of α-
tocopherol in combination with ascorbic acid and aspirin (as a thrombolytic drug) is more 
effective [8]. In the ASAP study, the combination of vitamins E plus C was also tested, and 
this significantly decreased the intima-to-media progression rates in human. The ATBC 
clinical study used a combination of vitamin E and β-carotene in human as a secondary 
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prevention strategy; however, no benefit on major coronary events has been found. The 
large MRC/BHF Heart Protection Study (HPS) for secondary prevention also examined the 
benefit of the antioxidant combination (vitamins E and C and β-carotene). 
A strong dose-dependent effect of α-tocopherol administration is one of the unwanted effects. 
It is known that even a slight increase of the α-tocopherol dose could affect lipoprotein 
oxidation, the endothelium function and the degree of systemic inflammation [12]. 
The results of Cambridge Heart Antioxidant Study (CHAOS) of using antioxidants in 
cardiology published in 1996 give the opportunity to say that in patients with true 
(confirmed by angiography) coronary atherosclerosis vitamin E administration (a daily dose 
of 544-1088 mg (400-800 МU) reduces the risk of non-fatal myocardial infarction. The overall 
mortality from cardiovascular diseases in this case does not decrease. A favourable effect is 
revealed only after one-year administration of tocopherol.  
At the same time in the Heart Outcomes Prevention Evaluation (HOPE) study, which was 
devoted to the study of the action of both ramipril and vitamin E (400 МU/daily dose), it 
was found that use of this antioxidant during approximately 4.5 years did not cause any 
effect on either the primary (myocardial infarction, insult and death from cardiovascular 
diseases) or any other end points of research. In another large-scale study on the primary 
prophylaxis of atherosclerotic diseases in people at least with one risk factors (hypertension, 
hypercholesterolemia, obesity, preliminary MI of the closest relative or advanced age) 
vitamin E (300 МЕ/daily dose) was used during 3.6 years and did not reveal any effect on 
any of the end points (the incidence of cardiovascular events and death). The vitamin E 
effectiveness was also not confirmed for various other cases (hypercholesterolemia, the level 
of sportsmen training, sexual potency, retardation of aging processes, etc.).  
Empirically vitamin E is used in various diseases; however, the majority of the reports about 
tocopherol effectiveness is based on the single clinical observation and experiment data. 
Nowadays there are no reliable results on the role of vitamin E in prevention of tumour 
diseases, though the ability to reduce formation of nitrosamines (potentially carcinogenic 
substances being formed in the stomach), to decrease the formation of free radicals and have 
antitoxic effects when using chemotherapeutic remedies is well-known. In addition, the 
long-term intake of vitamin E in the doses from 11 to 800 mg does not cause side effects.  
In HDL Atherosclerosis Treatment Study (HATS) there was the treatment of atherosclerosis 
depending on the high density lipoprotein cholesterol (HDL-C) level; in 160 patients with 
coronary heart disease with the confirmed coronary artery stenosis and the low HDL-C level 
the higher (800 МU/day) dose of vitamin E than in HOPE was used. The treatment 
combination also included 1000 mg of vitamin C, 25 mg of β-carotene and 100 mg of 
selenium. The study lasted 3 years and revealed that antioxidants had no influence on the 
HDL-C level, but in combination with hypocholesterolemic drugs they reduced their effect 
on LDL-C and especially – on HDL-C.  
The dominant carotenoid revealed in blood and various tissues (such as liver, kidneys, 
adrenal glands, ovaries and prostate) is lycopene. Due to its structure and mechanism of 
action lycopene belongs to the group of antioxidants; a lycopene molecule contains 13 
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double bonds, which can interact with free radicals. Like β-carotene lycopene can serve as a 
precursor of vitamin A. However, the lycopene antioxidant activity is two times stronger 
than that of vitamin A.  
Lycopene is recommended as an adjuvant in the treatment of the following diseases: 
idiopatic male infertility, chronic prostatitis, preeclampsia and intrauterine growth 
retardation (IUGR), mastopathia, diabetes mellitus, cardiovascular diseases, leucoplakia, 
age-related degeneration of yellow spots and cataract [17]. As with other oxidants, lycopene 
is administered in immunodeficiency states against chronic infections and to reduce the 
harmful action of unfavourable environmental factors.  
The most representative evidence of the antioxidants’ positive role in cardiovascular 
diseases prophylaxis was obtained in the multicultural European community multicentre 
study on antioxidants, myocardial infarction, and breast cancer (EURAMIC), during which 
the relationship between the antioxidant status and acute myocardial infarction in patients 
from 10 European countries was determined. The protective action was proven only for 
lycopene. In the Kuopio Ischemic Heart Disease Risk Factor Study (KIHD) the high level of 
blood plasma lycopene is associated with decreased risk of acute coronary syndrome and 
insult. In Erasmus Rotterdam Health Study (ERGO, also called “Rotterdam Study”) it has 
been proven that lycopene prevents development and progression of atherosclerosis. 
The meta-analysis of 72 epidemiological studies conducted concerning the connection 
between the tomato intake and cancer has determined the associative feed-back between the 
blood plasma lycopene level and the risk of cancer in 57 studies and 35 from 57 obtained 
associations were statistically significant [18]. 
Probucol (phenbutol) is a hypolipidemic medicine and belongs to butyl phenol derivatives. 
Probucol is the medicine that is similar in structure to hydroxytoluene – the compound with 
the potent antioxidant properties.  
The hypolipidemic effect of Probucol is caused by activation of non-receptor ways of LDL 
extraction from the blood. It is believed that the prominent antioxidant activity of probucol 
prevents LDL oxidation.  
Probucol decreases the total cholesterol content in plasma due to intensification of the LDL 
catabolism at the final stage of cholesterol elimination from the organism. It also inhibits the 
cholesterol biosynthesis at early stages and to a small extent slows down the food 
cholesterol absorption. It does not influence the triacylglycerol and the VLDL content, but 
significantly decreases the antiatherogenic HDL level in the blood. It is believed that 
decrease of the HDL-C level reflects improvement of cholesterol esters transfer with HDL on 
acceptor lipoproteins due to increase of the cholesteryl ester transfer protein (CETP) activity.  
In spite of undesired decrease in the HDL-C concentration probucol causes regression of 
xanthelasma; this effect is revealed best of all in patients with the most dramatic HDL-C 
decrease. This important observation demonstrates that the low HDL-C content is not 
undoubtedly a negative phenomenon. The data obtained in experiments with animals indicate 
that probucol due to its antioxidant properties prevents lipid peroxidation and thereby inhibits 
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the LDL uptake by macrophages, therefore, it inhibits atherogenesis. This allows suggesting 
that the therapeutic effect of the medicine may not be connected with its ability to decrease the 
LDL level. There is no clinical evidence of this hypothesis at the moment.  
The medicine is absorbed slowly when taken internally, it is readily soluble in the adipose 
tissue releasing gradually into the bloodstream, and so its action is kept for a long time (up 
to 6 months after discontinuation of the treatment).  
When using probucol in MultiVitamins and Probucol (MVP) research the renewal of the 
endothelium function in patients with IHD, decrease of restenosis cases after coronary 
angioplasty (when taking it at least 4 weeks before the procedure and further treatment 
during 6 months) was observed. Other antioxidants (α-tocopherol in high doses (700 mg per 
day), β-carotene and vitamin C) turned out to be ineffective.  
Combined application of the endogenous antiradical antioxidants is of particular interest. In 
HPS (Heart Protection Study) along with the study of the simvastatin effectiveness the 
prophylactic action of antioxidants was investigated. The use of the vitamin complex (600 
mg of vitamin E, 250 mg of vitamin C and 20 mg of β-carotene per day) lasted in average 5.5 
years and did not reveal any differences in placebo groups and groups taking vitamins. 
Moreover, if the tendency exists, it reflects increasing of vascular events in the antioxidant 
intent-to-treat group. The action of antioxidants was compared with the effect of the 
combined use of simvastatin and nicotinic acid (niacin). Moreover, one of the groups 
received simvastatine+niacin and antioxidants. Angiographic and clinical data of this study 
were also disappointing with respect to the use of antioxidants.  
Unfortunately, a great part of the compounds synthesized, which are used for 
pharmacocorrection of these states, are xenobiotics, so they can activate the free-radical 
formation process. Synthetic antioxidants, in particular probucol, can not be recommended 
for patient use because they decrease the HDL-C level.  
The lack of antioxidant medicines popularity and the absence of traditions of their common 
use in practical medicine are caused a number of reasons: unsatisfactory previous study of 
this issue, complexity of adequate estimation of oxidation state parameters in the organism 
and the absence of the effective medicines with the antioxidant activity that are able to 
quickly reduce the consequences of the oxidative stress.  
Therefore, the main indications for using antioxidants are excessively activated free-radical 
oxidation processes accompanying different pathologies. The choice of specific medicines, 
correct indications and contraindications for their use has not been developed yet and 
require further research. 
3. Experiment design 
In our experiments we studied the indicators of lipid and lipoprotein metabolism in the 
blood plasma and the liver under the experimental metabolic syndrome (MS) in Syrian 
hamsters of different sex and age.  
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In the experiments purebred male rats with 180-220 g of the body weight were used. The 
animals were kept in vivarium on a balanced diet. During 21 days the animals were given 
low alcoholic beverages from grapes of red and white grades per os daily. These beverages 
were introduced in the maximum effective doses of 9 mg of polyphenols/100 g the body 
weight. Taking into account the fact that the polyphenol content in the beverages 
investigated was quite low, the effective dose was introduced 3 times a day by 2 ml of 
liquids per 100 g of the animal’s body weight. Control animals were introduced the 
corresponding volume of the saline solution. Ethanol was given in the corresponding dose. 
Stress was caused by immobilization on the abdomen for 3 hours [19]. Animals were 
decapitated 3 hours after the immobilization. The blood was collected to get the serum. The 
liver was perfused by the cold extraction medium (0.25 M sucrose in 0.025 M tris-HCl, pH 
7.5), homogenized in the Potter homogenizer with 2 ml of the extraction medium per 1 g of 
the liver. All manipulations with animals were held under chloralose-urethane anaesthesia. 
To distribute the plasma lipoproteins the samples were centrifuged at 65,000 rpm (342,000 g) 
for 4 h at 4°C in the Optima XL-100K ultracentrifuge (Beckman Coulter) set at slow 
acceleration and deceleration [20]. Samples were fractionated within 1 h of centrifugation.  
Lipids were extracted with chloroform and methanol (1:2 v/v) twice, as described by Bligh et 
al [21], and the supernatant was collected for determination of TG and FFA. TG and FFA 
were determined by enzymatic colorimetric methods with commercial kits (Zhongsheng, 
Beijing, China). The total cholesterol content was detected with the help of standard 
enzymatic cholesteroloxidase kits of “Boehringer Mannheim GmbH diagnostica” firm 
(Germany). The total lipid concentration was determined with the help of a standard kit 
“Eagle Diagnostics” (USA) – the reaction with vanillin reagent. 
Determination of the lipid peroxide product quantity was performed in heptane-
isopropanol extracts [22]. The optical density was measured at the wavelength of 220 nm 
(for compounds with isolated double bonds), 232 nm (for diene conjugates) and 278 nm – 
for ketodienes and conjugate trienes. 
The TBA content was determined on the spectrophotometer with the help of the reaction 
with thiobarbituric acid [23]. 
A modified version of the high performance liquid chromatography (HPLC) procedure 
developed by Stacewicz-Sapuntzakis et al. [24] was used to measure vitamins E in the 
plasma. The HPLC system included a 150 × 3.9 mm Nova-pak C18 (4 microns) column with 
a guard-pak pre-column (both from Waters, Milford, MA), Waters Millipore TCM column 
heater, Waters 490 multi-wavelength detector, Hitachi 655–61 processor, Hitachi 655A-11 
liquid chromatography, and BioRad autosampler AS-100.  
The serum ascorbic acid concentrations were measured as described by using HPLC [25] 
with salicylsalicylic acid as a deproteinizing agent, metaphosphoric acid as a stabilizer. 
The serum PON1 activity was measured by the rate of generation of p-nitrophenol 
determined at 405 nm according to MacKness B et al. [26]. 
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The plasma cholesterol ester transfer protein (CETP) activity was examined using the 
modifications of Khosla et al. [44]. The CETP activity in duplicate10-μL aliquots of the 
plasma was determined after incubations with 3H-cholesterol ester (CE)-labeled HDL3 and 
LDL. Radioactivity transferred from 3H-HDL3 to LDL (measured in the supernatant after 
precipitation with heparin/MnCl2+) was used to calculate the CETP activity (expressed as the 
percentage of radioactivity transferred from 3H-HDL3 to LDL per 16 h of incubation).  
To measure endothelium-bound LPL, the perfusion solution was changed to buffer 
containing 1% fatty acid–free BSA and heparin (5 units/ml). The coronary effluent was 
collected in timed fractions over 10 min and assayed for the LPL activity by measuring the 
hydrolysis of a sonicated [3H]triolein substrate emulsion [27]. 
The plasma LCAT activity was measured by determination of the amount of radioactivity in 
each spot calculating the free cholesterol/ total cholesterol ratio in each plasma sample 
before and after the LCAT reaction and thus estimating the esterification rate [28]. The 
fractional esterification rate (% . h’) expressed as the percentage of the free cholesterol 
esterified in the plasma sample per hour. 
The HL activity was evaluated using the glycerol-stabilized emulsion of triolein and egg 
phosphatidylcholine containing glycerol-tri[9,10(n)-3H] oleate by determination of the 
radioactivity amount during incubation [29]. 
Statistical analysis. All data were analyzed for statistical significance with SPSS 13.0 
software. The data were presented as means ± standard deviation. Statistical analysis used 
one-way ANOVA. P<0.05 was considered to be statistically significant. 
4. Discussion 
The results of our studies suggest the existence of significant changes in the lipid 
metabolism, as well as sex and age differences in the lipid and lipoprotein metabolism both 
in healthy animals and in animals with MS.  
In male hamsters fed with a high-calorie diet atherogenic dyslipidemia develops 
independently of age (Table 1). As it can be seen from the data obtained, increase of the total 
lipid content in the animal blood plasma is caused by increasing of the ApoB-containing 
lipoprotein (ApoB-LP) level since the HDL content is not changed. At the same time it has 
been found that the plasma TAG level in young (47%) and in adult animals (30%) increased 
in comparison with the intact group. 
Increase of the TAG blood content in conditions of MS is considered to be a key factor for 
development of atherogenic dyslipidemia that is typical for this pathology [30]. A strong 
correlation between hypertriacylglycerolemia plus the HDL-C level decrease and 
accumulation of LDLB in the blood plasma has been demonstrated in many experiments 
and clinical studies [18]. 
It is assumed that atherogenic alterations occur as a result of lipoprotein disbalance in the 
blood plasma, i.e. because of predominance of the LDL and VLDL fractions over the 
Antioxidant Complexes and Lipoprotein Metabolism –  
Experience of Grape Extracts Application Under Metabolic Syndrome and Neurogenic Stress 453 
antiatherogenic HDL fraction (especially when the values of the LDL+VLDL/HDL index are 
higher than 3.5). 
 
Age Group 
Parameters
TAG, 
g/L 
Total 
cholesterol, 
mmol/L
ApoB-LP, 
g/L 
HDL, 
g/L 
4 weeks 
Intact 1.06±0.07 2.93±0.19 4.72±0.23 1.11±0.05 
MS 1.56±0.09* 3.56±0.10* 6.68±0.15* 0.98±0.07 
20 weeks 
Intact 1.57±0.22 2.84±0.15 5.66±0.34 1.01±0.02 
MS 2.00±0.13* 3.71±0.18* 6.68±0.21* 0.85±0.08 
1 year 
Intact 1.50±0.10 2.730.02 5.21±0.06 1.74±0.13 
MS 2.27±0.13* 3.150.08* 7.00±0.22* 2.32±0.13* 
The data presented as mean±SD 
* –р0.05 versus intact animals 
Table 1. Some plasma lipid values in male Syrian golden hamsters with MS (in each group n=10). 
As it is known, there are 2 phenotypes of LDL: LDLA and LDLB that differ by size, density, 
the lipid content and the atherogencity coefficient. LDLB have less size (d 25.5-25.75) 
comparing to LDLA (d > 25.75) and are characterized by a lower content of polar lipids, as 
well as a higher content of cholesterol esters. Lipoproteins of this subfraction are slowly 
removed from the bloodstream that is caused by their low affinity to B/E-receptors for LDL, 
higher sensitivity to glycosylation and oxidative damage [31]; they also have a high affinity 
to scavenger-receptors of macrophages [32]. 
All this features explain a high atherogenicity of LDLB subfraction. Numerous clinical and 
epidemiological studies have confirmed that accumulation of LDLB in the blood is an 
independent risk factor for atherosclerosis occurrence [33]. 
Normally, there are predominantly LDLA in the blood plasma, and LDLB are present in a 
small percent of the total LDL, but in MS and insulin resistance the LDLB content increases 
significantly.  
It is well-known that in MS the key factor for TAG and ApoB-LP accumulation in the blood 
is the VLDL hyperproduction by the liver [34]. According to our data, accumulation of 
ApoB-LP in the blood occurs parallelly with increase in the content of this lipoprotein 
fraction in the liver (Table 2). 
These results allow us to make a suggestion that VLDL formation is activated in the liver of 
the animals fed with a high-calorie diet in our experiment.  
The mechanisms of the VLDL hyperproduction by the liver in the conditions of FFA 
intensive supply to hepatocytes have remained still unclear. The stimulation of VLDL 
formation can occur both by using the elevated uptake of the blood FFA and via activation 
of fatty acid biosynthesis de novo because of hyperglycemia. 
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Age Group
Parameters
Total lipids, 
mg/g liver 
ApoB-LP, 
mg/g liver 
HDL, mg/g 
liver 
G6PDH, 
nmol/mg 
protein/min 
Lysosomal 
lipase,  
nmol/mg 
protein/min 
Week 4 
 
Intact 104.24±2.52 11.46±0.37 1.25±0.14 3.74±0.33 0.67±0.03 
MS 124.16±2.05* 15.16±0.54* 1.11±0.07 2.80±0.17* 1.09±0.07* 
Week 20 
Intact 112.62±2.66 13.03±0.50 0.94±0.10 4.44±0.28 0.54±0.03 
MS 143.59±2.65* 15.69±0.36* 1.10±0.20 3.13±0.28* 1.27±0.09* 
The data presented as mean±SD 
* –р0.05 versus intact animals 
Table 2. Some liver lipid metabolism values in male Syrian golden hamsters with MS used in the 
current study (in the crude tissue, in each group n=10). 
It is known that in insulin resistance FFA that come to hepatocytes from the blood are 
primarily used for the TAG re-synthesis. It leads to increase in the intracellular TAG content 
and correlates with the increase of the VLDL secretion rate into the bloodstream. The VLDL 
morphology, which is specified predominantly at the second stage of their formation, 
depends significantly on the intracellular TAG content and hepatocyte sensitivity to insulin 
[35]. More active phospholipase D-dependent pre-VLDL lipidation takes place in the 
elevated intercellular TAG content and insulin resistance of hepatocytes [36]. Insulin blocks 
the VLDL1 formation in the liver. In the conditions of insulin resistance this effect and the 
elevated intercellular TAG content stimulate formation and secretion predominantly of 
VLDL1 by the liver [37].  
The VLDL1 secretion increase leads to significant changes in the lipid and lipoprotein 
metabolism in the blood: the increased TAG content and accumulation of LDLB with high 
atherogenicity in the blood. These changes are typical for MS and considered to be separate 
risk factors for development of atherosclerosis. 
Metabolism of ApoB-LP in the blood plasma is tightly connected with metabolism of HDL 
performing a reverse cholesterol transport from peripheral tissues to the liver. The leading 
factors in the process of transformation of VLDL into LDL in the bloodstream and 
determination of the LDL morphology are the rate of cholesterol esters transfer from HDL to 
ApoB-LP mediated by cholesteryl ester transfer protein (CETP), and the rate of TAG 
hydrolysis in the ApoB-LP composition mediated by lipoprotein lipase (LPL) and hepatic 
lipase (HL) [38].  
According to data of many clinical studies, increase of the CETP activity of the HDL 
composition in most cases leads to decrease of the HDL-C level and accumulation of LDLB 
in the blood plasma. Moreover, a degree of these modifications correlates with the blood 
TAG level. 
We observed significant changes in the cholesterol and HDL metabolism in the blood plasma 
in animals fed with a high-calorie diet. These changes have expressed the proatherogenic 
character and could be one of the causes for the LDLB accumulation in the blood.  
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Our results suggest that increase of the total blood cholesterol level in hamsters fed with a 
high-calorie diet is obviously connected with increase of the cholesterol content in the ApoB-
LP composition as its level in the HDL composition decreases (Table 3). 
 
Age (at the 
beginning of the 
experiment) 
Group 
Parameters 
HDL-C, 
mkmol/L 
HDL-CE, 
mkmol/L 
LCAT, 
mkmol/l/h 
CETP, 
mkmol/l/h 
Week 4 
Intact 174.1718.99 1028.3312.76 54.920.58 20.421.76 
MS 80.839.17* 810.0022.78* 49.002.50 33.831.56* 
Week 20 
Intact 138.008.00 770.0032.56 45.502.55 59.505.39 
MS 164.509.97 512.500.01* 20.252.28* 116.889.43* 
The data presented as mean±SD 
* –р0.05 versus intact animals, а –р0.05 versus intact animals 4 weeks. 
Table 3. Plasma HDL-C and HDL-CE, cholesterol esterifying activity and CE transfer in Syrian golden 
hamsters with the experimental MS (in each group n=10). 
Decrease in the HDL cholesterol level is apparently connected with increase of the transfer rate 
of cholesteryl esters from HDL to ApoB-LP. According to our data the rate of the cholesteryl 
esters transfer from HDL in the animals fed with a high-calorie diet grows to 166% and 199% 
compare to the values of young and adult intact animals, respectively (Table 3).  
At the same time decrease in the free cholesterol and HDL esterified cholesterol levels was 
determined in young males, but in adult animals only the HDL esterified cholesterol content 
lowered. The cholesteryl ester transfer rate from HDL to ApoB-LP is activated when the 
TAG content increases in the blood, it is observed in the postprandial period, as well as in 
ApoB-LP metabolism abnormalities [39]. In both cases the cholesteryl ester transfer 
activation is a consequence of increasing the TAG-rich lipoproteins (TRL) in the 
bloodstream [40]. The latter is also confirmed by our data pertaining to the increase of the 
neutral lipids content in the ApoB-containing lipoproteins in hamsters with the 
experimental MS. These differences seem to be connected with the difference in the HDL 
free cholesterol esterification rate in males of various ages. This rate is primarily determined 
by the activity of LCAT – the enzyme associated with HDL [41]. 
The increase of the cholesteryl-ester transfer activity from HDL is mostly the result of the 
CETP activation. The increase of the CETP activity in MS was demonstrated in a great 
number of experiments [22]. It is known that the activation of CETP biosynthesis in the liver 
is primarily the cause for increasing the activity of this protein in the blood HDL 
composition, but mechanisms of CETP induction have been still unclear.  
Thus, increase of the cholesteryl ester transfer rate from HDL on the background of 
hypertriacylglycerolemia, which is observed in our experiment in the animals fed with a 
high-calorie diet (Table 3), is atherogenic since the cholesteryl ester transfer predominantly 
to TAG-enriched lipoproteins leads to accumulation of CE-enriched VLDL1, which are 
major precursors of LDLB. Intensive TAG supply to HDL in exchange for cholesteryl esters 
results in accumulation of TAG-enriched HDL particles, which are the predominant 
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substrate for hepatic lipase (HL), in the blood. So, HDL particles are rapidly removed from 
the bloodstream and it leads to decrease of the HDL-C content. 
That is why changes in the enzymes activity, which hydrolyze lipoprotein lipids in the 
bloodstream, in particular – in LPL and HL activity, affect significantly the lipoprotein 
metabolism in MS. 
TAG in the TAG-enriched lipoproteins (chylomicrons and VLDL) are the substrate for LPL. 
FFA, released after hydrolysis under the action of LPL, come to adipocytes and muscle cells 
where they are deposited as the TAG component or used as a source of energy. TAG 
hydrolysis in the VLDL composition increases availability of cholesterol for its transfer to 
HDL, therefore, in this way LPL mediates the reverse cholesterol transfer. The LPL activity 
is regulated by the influence on transcription, translation and enzyme transport from the 
cells. Insulin is known to activate LPL that results in decrease of the total blood TAG level 
and stimulation of cholesterol reverse transfer [35]. 
According to our data, the plasma LPL activity decreased in young male hamsters fed with 
a high-calorie diet (Table 4). 
 
Age (at the beginning of 
the experiment) 
Group 
Parameters 
LPL (U/ml) HL (U/ml) 
Week 4 
Intact 8±2 51±4 
MS 4±1* 91±3* 
Week 20 
Intact 83±2 3±1 
MS 129±3* 2±1 
The data presented as mean±SD 
* –р0.05 versus intact animals 
Table 4. Postheparin plasma lipase activities in Syrian golden hamsters with the experimental MS (in 
each group n=10). 
The results obtained are in agreement with the literature data about the reduction of the LPL 
activity in obesity and insulin resistance [42]. The mechanisms of the LPL activity inhibition 
in these conditions are still unclear though a definite contribution could be made by 
development of insulin resistance. 
The increase of the cholesteryl ester transfer rate from HDL on the background of 
hypertriacylglycerolemia, which was stated in our experiment both in animals fed with a 
high-calorie diet and in chronic stress, is an atherogenic factor for two reasons. Firstly, the 
cholesteryl ester transfer predominantly to the TAG-enriched lipoprotein fractions leads to 
accumulation of VLDL1 enriched with cholesteryl esters, which are the main LDLB 
precursors. Secondly, the intensive exchange of cholesteryl esters in HDL for TAGs results 
in accumulation of TAG-enriched HDL in the blood, which are the predominant substrates 
for HL, and they are rapidly removed from the bloodstream, and it, in turn, causes decrease 
in the HDL-C concentration. The activation of the lipoprotein secretion by the liver is also 
observed in the conditions of the acute chemical and emotional painful stress. This fact may 
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be considered to be a sign of proatherogenesis since it is accompanied by hyperlipidemia 
development due to increase of atherogenic lipoprotein fractions.  
As shown in our studies, decrease of the LPL activity in the blood plasma of young males 
fed with a high-calorie diet can be an additional factor for TAG accumulation in the blood 
and the HDL-C level reduction observed in our experiment. 
HL mediates a selective transport of VLDL remnants to hepatocytes via LDL-receptors, 
takes part in reverse transport of cholesterol accelerating HDL coming into the liver via 
scavenger receptors (SRB1). Hydrolyzing TAG in the ApoB-LP composition HL plays a 
significant role in their re-modelling in the bloodstream. It is known that the HL activity 
specifies substantially the lipid composition, size and properties of LDL [43]. 
The HL activity is predominantly regulated at the transcriptional level under the influence of 
sex hormones, glucocorticoids and adipokines. The rate of the HL gene transcription is also 
dependent on the intercellular lipid content, primarily cholesterol in the hepatocytes [44]. 
In our experiment the blood plasma HL activity in male hamster fed with a high-calorie diet 
increased irrespective of age (Table 4), it corresponds to literature data. In a number of studies 
it has been shown that the HL activity increases in insulin resistance, obesity, and a high-
calorie diet [45]. Moreover, it has been determined that increase of the HL mRNA content is 
observed when using a high-calorie diet; this is the evidence of the enzyme biosynthesis 
activation under these conditions. The authors associate this fact with the decrease in the blood 
plasma adiponectin level, which can inhibit the HL synthesis in hepatocytes. 
Considering these data, as well as the data obtained in our studies about adiponectin 
decrease in the blood plasma in obesity (Fig. 1), we may suppose that one of the causes for 
the HL activity increasing when taking a high-calorie diet in our experiment is decrease of 
adiponectin secretion by the adipose tissue. 
The HL activity increase is considered to be one of the key factors for the atherogenic 
dyslipidemia development in obesity and MS. In a number of works a clear correlation 
between the HL activity and the LDLB content in the blood plasma was demonstrated [19]. 
It is believed that namely HL activation results in the increased LDLB formation [33]. The 
latter occurs with increase of the TAG-enriched VLDL1 content in the blood and the CETP 
activation. Furthermore, the HL activity increase leads to decrease of the HDL cholesterol 
level [46]. This is associated with the fact that hydrolysis of TAG in the HDL3 composition 
results in their transformation into HDL2, which are rapidly removed from the bloodstream 
by the liver. Thus, the HDL-C level decrease that we determined in our experiment (Table 3) 
can be a consequence of the HL activity increase.  
In the current study we have found that the blood FFA level increase is accompanied by the 
ApoB-LP synthesis activation in the liver of Syrian male hamsters fed with a high-calorie 
diet irrespective of age. This causes increase of the TAG and ApoB-LP level in the blood. 
Decrease of the HDL-C level is a consequence of the rate of cholesteryl ester exchange 
between HDL and LDL due to activation of CETP and HL. As a result of these changes the 
atherogenic dyslipidemia development, which is typical for MS, is observed. 
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Figure 1. Plasma adiponectine level in Syrian golden hamsters with the experimental MS development 
(values are mean±SD; * –р0.05 versus intact animals, in each group n=10, * – p < 0.05 versus intact animals). 
We have found the age differences of the lipid profile in the blood plasma of the normal 
male hamsters. So, in intact males (with age from 4 to 20 weeks) on the background of the 
constant content of total lipids and lipoproteins in the blood plasma there was increase of 
the FFA level (60% comparing to a 4-week intact), TAG (48%) and ApoB-LP (20%), and the 
HDL level showed a tendency to decrease. These results are the evidence of the lipidation 
increase with age. It has been also shown that in adult males the unesterified cholesterol and 
cholesteryl ester levels are lower than in young animals (20% and 25%, respectively), and 
the cholesteryl ester transfer rate from HDL in adult animals exceeds this index value in 
young animals (191%) (Table 3). 
The data obtained correspond to the literature data about age-dependent changes in the lipid 
metabolism in males, which have the proatherogenic character [47]. It is known that with age 
the sex hormones level lowers in males and the glucocorticoid secretion level increases. The 
plasma lipid profile in males is determined, among other factors, by the secretion level of sex 
hormones possessing antiatherogenic properties. A lot of studies proved the presence of direct 
correlation between the blood testosterone plus the dehydrotestosterone level and the HDL-C 
content [48]. Moreover, the high level of sex hormones correlates with decrease of the TAG 
content and the total cholesterol in the blood. Thus, increase of the TAG level and decrease of 
the HDL cholesterol content in the blood plasma of males with age may be connected with 
reduction of the sex hormone secretion (Table 5). Changes of the lipid profile in the blood 
plasma of males with age may be also associated with increase of glucocorticoid secretion, 
which was observed in our experiment (Table 5). 
Thus, with age the blood plasma lipid profile in males is subjected to unfavourable changes 
such as increase of the FFA and TAG content and decrease of HDL-C. The latter may be 
connected with decrease of the sex hormone level, and increase of the cortisol secretion. 
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However, despite the more favourable lipid profile in the blood plasma of young males 
comparing with normal adult animals, atherogenic dyslipidemia in obesity and insulin 
resistance develops irrespective of age.  
In contrast with males, in females the atherogenic dyslipidemia development is significantly 
dependent on age (Table 6). In particular, while in males with age there are no significant 
changes in the liver ApoB-LP content, in females this index raises during maturation – in 
intact animals – to 20%, and in animals in the experimental MS – to 31%. That indicates 
intensification of lipolytic processes in the liver of females during ageing, and may serve as 
a manifestation of the lipid metabolism activation. The analogous changes in the total lipid 
content also proved this tendency (Table 6).  
 
Sex Parameter Group 
Age (at the beginning of the experiment) 
4 weeks 20 weeks 1 year 
Females 
Estradiol, 
pmol/mL 
Intact 0.550.05 0.640.06 0.540.05 
MS 0.630.06* 0.750.08 0.360.04* 
Cortisol,
nmol/L 
Intact 47.003.85 73.175.56 76.00±4.95 
MS 74.05.49* 87.54.45 117.00±2.63* 
Males 
Estradiol, 
pmol/mL 
Intact 0.240.02 0.190.02 0.290.03 
MS 0.270.02 0.290.02* 0.200.03* 
Testosterone, 
pmol/mL 
Intact 4.020.39 4.240.31 3.580.37 
MS 4.450.41* 3.510.40* 3.030.31* 
Cortisol,
nmol/L 
Intact 61.173.71 94.83.06 85.33±5.40 
MS 84.673.62* 132.007.88* 148.40±9.54* 
The data presented as mean±SD 
* –р0.05 versus intact animals 
Table 5. Plasma sex hormones and cortisol levels in hamsters with the experimental MS (in each group 
n=16) 
 
Age Group 
Parameters
Total lipids, mg/g
ApoB-LP, mg/g 
liver 
HDL, mg/g 
Lysosomal lipase, 
nmol/mg 
protein/min 
4 weeks 
Intact 117.674.72 8.870.24 1.270.08 0.340.03 
MS 144.345.00* 10.240.25* 0.650.05* 1.240.05* 
10 
weeks 
Intact 137.543.91 10.650.46 0.890.07 0.830.04 
MS 179.223.44* 13.440.30* 0.460.06* 1.330.08* 
The data presented as mean±SD 
* –р0.05 versus intact animals 
Table 6. Lipid metabolism parameters in the liver homogenate in Syrian golden female hamsters with 
MS (in the crude tissue, in each group n=16) 
Oxidation of LDL and VLDL (i.e. ApoB-LP) is an alternative way of the lipoprotein 
catabolism, which leads to their uptake by macrophages via scavenger-receptors, and may 
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lead to the transformation of these cells into “foam” ones. That is why it is one of the factors 
of atherogenesis in MS. 
In our experiment we also observed the composition changes in lipoproteins and in particular 
HDL particle enrichment with lipids (Table 7). However, the cholesterol content of these 
lipoproteins decreased in contrast to the ApoB-LP cholesterol content that was increased. 
 
Parameters 
Group 
Intact MS 
Total lipids, % of the total HDL composition 49.451.35 57.311.91* 
Total cholesterol, % of the total HDL composition 14.970.23 11.210.76* 
TAG, % % of the total HDL composition 1.750.07 3.080.15* 
-Tocopherol, mmol/L 8.020.39 5.700.35* 
Isolated double bonds, U/ml 8.640.59 7.310.17* 
Diene conjugates, mmol/L 18.882.10 31.681.65* 
Ketodienes+conjugated trienes, U/ml 1.150.08 1.480.06* 
Total hydroperoxides, mmol/L 69.043.46 78.311.33* 
The data presented as mean±SD or percentage 
* –р0.05 versus intact animals 
Table 7. The plasma HDL composition in Syrian golden hamsters (1 year) with the experimental MS  
(in each group n=10). 
There are several possible reasons for that phenomenon. One of them is a well-known fact 
that HDL contains high levels of both unsaturated fatty acids, which are rapidly utilized, 
and proteins, which hydrophilic properties compensate the lack of phospholipids, as well as 
α-tocopherol and enzymatic antioxidants, particularly paraoxonase, which protect these 
lipoproteins from peroxidation. There is no doubt that the changes in the cholesterol 
metabolism enzymes activity associated with HDL (CETP) are involved in this process 
(Table 3).  
Nevertheless, the content decrease of compounds with isolated double bonds and 
accumulation of the lipoperoxidation products has been determined in the HDL fraction in 
MS (Table 7). Moreover, the data obtained have shown that the content of ketodienes and 
coupled trienes in the HDL fraction is 129% comparing to control; the content of diene 
conjugates – 168% and the content of the total hydroperoxides – 115%. It has been also 
found that there is decrease of the α-tocopherol content in HDL (41%) comparing to the 
control values (Table 7). 
Thus, HDL can protect LDL from oxidation “providing” a cell with paraoxonase and PAF-
acetyl hydrolase. However, this protective effect of HDL is reduced in response to induction 
of the stress acute phase in animal models [49]. 
As can be seen from our data (Table 8), the HDL-associated paraoxonase activity is generally 
decreased in experimental MS. 
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Sex Age Groups 
Activity,  
nmol/mL/min 
Males 
4 week 
Intact 80.783.69 
MS 67.063.70* 
20 week 
Intact 62.192.63 
MS 37.293.33* 
Females 
4 week 
Intact 104.412.95 
MS 75.452.21* 
20 week 
Intact 127.272.95 
MS 121.933.05 
The data presented as mean±SD 
* –р0.05 versus intact animals 
Table 8. The plasma HDL paraoxonase activity in Syrian golden hamsters with experimental MS (in 
each group n=10). 
The data obtained show that application of antioxidant complexes for correction of 
unfavourable changes in proatherogenic states may be perspective since free radical 
oxidation activation is a common pathogenetic link of all those states; this link is not only 
involved in damage of cells and their components, but also as an alternative way of 
catabolism it accelerates the lipid recyclization. 
At the same time, since a significant feature of proatherogenic states is the hormone status 
imbalance, polyphenolic antioxidants need special attention because these compounds 
along with the antioxidative activity also demonstrate phytoestrogen properties [50], and it 
may be an additional factor of the lipid metabolism regulation. 
An important effect of flavonoids is scavenging of oxygen-derived free radicals. The 
experimental systems in vitro have also shown that flavonoids possess anti-inflammatory, 
antiallergic, antiviral, and anticarcinogenic properties. The so-called ‘‘Mediterranean diet’’ is 
thought to prevent cardiovascular diseases, as a consequence of its high content of 
antioxidants, which are crucial in ameliorating oxidative events implicated in many 
diseases. In addition to the antioxidant/antiradical activity, red wine polyphenols (RWPs) 
have been shown to possess many biological properties, including inhibition of platelet 
aggregation, the vasorelaxing activity, modulation of the lipid metabolism, and inhibition of 
the low-density lipoprotein oxidation. 
In our research we have used wine, juice and polyphenolic extracts from grapes of different 
grades, and polyphenolic concentrates “Enoant” and “Polyphen” obtained from Vitis 
Vinifera grapes to correct the changes in the lipid metabolism in the conditions of the 
experimental metabolic syndrome, acute and chronical stress. All substances used in our 
research were developed in National Institute for Vine and Wine "Magarach" (Yalta, 
Ukraine). The studies carried out have specified that polyphenolic extracts and concentrates 
are quite active remedies that decrease negative effects in MS though the effectiveness of 
various substances administered are significantly different.  
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So, administration of any of the investigated substances has significantly decreased the total 
blood plasma lipoprotein content in hamsters with MS, but the use of “Cabernet” extract has 
the most pronounced effect (Fig. 2). The same tendency is observed in decreasing the ApoB-
LP content, the total cholesterol and FFA level have also decreased, though practically no 
difference between the grape varieties investigated has found.  
 
* – р0.05 versus intact animals. 
Figure 2. The effect of Vitis Vinifera substances on some plasma lipid metabolism values in male Syrian 
golden hamsters (1 year old) with the experimental MS (in each group n= 7)  
The non-enzyme antioxidant level (α-tocopherol, reduced glutathione and ascorbic acid) in 
the blood serum has also reached reference values under the influence of the polyphenolic 
extracts. This fact confirms the high antioxidant activity of the studied substances. 
Normalization of the blood plasma phospholipid content under the influence of polyphenolic 
extracts arouses the interest. The phospholipid content returned to the intact level, which may 
be a result of their oxidation reduction, given that the unsaturated fatty acids in phospholipids 
are compounds that undergo oxidation by free radicals quickly and easily. 
However, in spite of the quite favourable effect of “Isabella” extract, its administration also 
has negative consequences, particularly the HDL level decrease to the value observed in 
intact animals accompanied by the LDL content increase. 
The investigated substances normalize also the blood lipoproteins composition. Thus, the 
total lipid and the total cholesterol content decrease in the ApoB-LP composition, moreover 
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“Enoant” lowers the cholesterol content in this atherogenic lipoprotein fraction even below 
the control level. 
Generally, the TAG content is also normalized under the action of all the investigated 
substances, but taking into account the ratio – cholesterol/triacylglycerols, “Polyphen” has 
the most favourable effect. 
The polyphenol extracts and concentrates have significantly improved the ApoB-LP 
oxidative status in animals with MS. The best results have been obtained when using 
“Cabernet”, as well as for other indexes investigated (Table 9). 
 
Parameter 
Group
MS MS 
+“Enoant”
MS 
+“Polyphen”
MS+
“Isabella” 
MS+ 
“Cabernet” 
Total lipids, % of the total 
ApoB-LP composition
88.87
0.71*
83.70
0.78 */**
83.12
0.37*/**
82.22
0.09*/** 
81.00 
0.19* 
Total cholesterol, % of the total 
ApoB-LP composition
8.39
0.24
7.87
0.04*/**
8.13
0.04
8.06
0.12** 
8.17 
0.08*/** 
TAG, % of the total ApoB-LP 
composition
37.55
1.89*/**
53.97
0.10*/**
53.02
0.14*/**
50.65
1.23*/** 
49.57 
0.40*/** 
 - Tocopherol, mmol/L 2.680.08*
2.98
0.05*/**
3.06
0,04*/**
3.17
0,02*/** 
3.19 
0,05*/** 
Isolated double bonds, U/ml 
1.71
0.06*
1.84
0.03*/**
1.90
0.02*/**
1.97
0.03** 
2.09 
0.03** 
Diene conjugates, mmol/L 
37.25
1.50*
30.63
0.41*/**
29.54
0.34*/**
28.77
0.14*/** 
26.68 
1.94** 
Ketodienes+conjugated trienes, 
U/ml
8.18
0.11*
7.49
0.04*/**
7.23
0.08*/**
7.17
0.08*/** 
6.99 
0.26** 
Total hydroperoxides, mmol/L 
108.25 
1.39* 
98.52 
0.55*/** 
94.97 
0.15*/** 
90.65 
1.15*/** 
89.30 
1.06*/** 
The data presented as mean±SD or percentage 
* – р0.05 versus intact animals, ** – р0.05 versus model of MS  
Table 9. The effect of Vitis Vinifera substances on the plasma ApoB-LP composition in male Syrian 
golden hamsters (1 year old) with the experimental MS (in each group n= 10) 
The HDL composition in the blood is also affected by the substances studied. In these 
particles the total lipid content decreases and even reaches the level of intact animals when 
using “Cabernet” extract (Table 10). 
The cholesterol level also changes: it decreases when using “Enoant” and increases under 
the action of “Isabella” and “Cabernet” extracts. 
The HDL-C content decreases under the action of “Enoant” may occur due to peroxide 
processes inhibition since cholesterol accumulation in lipoprotein particles, as it was 
mentioned before, has a compensatory character in response to the phospholipid oxidation 
of the lipoprotein particle hydrophilic cover. The TAG content decreased under the action of 
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all substances, and “Isabella” was the most effective substance. The TAG content decrease is 
probably mediated by the phytoestrogenic action of polyphenols directed to lipolysis 
inhibition in the adipose tissue. 
 
Parameter 
Group
MS MS 
+“Enoant”
MS 
+“Polyphen”
MS+
“Isabella” 
MS+ 
“Cabernet ” 
Total lipids, % of the total ApoB-
LP composition
57.31
1.91*
54.91
0.21*/**
53.09
0.08*/**
51.74
0.74*/**
49.20 
0.42** 
Total cholesterol, % of the total 
ApoB-LP composition
11.21
0.76*
10.54
0.30*/**
11.14
0.04*
12.05
0.21*
12.45 
0.34*/** 
TAG, % of the total ApoB-LP 
composition
3.08
0.15*
2.90
0.09*/**
2.11
+0.12*/**
1.92
0.04*/**
1.96 
0.03*/** 
 - Tocopherol, mmol/L 5.700.35*
7.47
0.20*/**
7.19
0.17*/**
7.36
0.11*/**
8.13 
0.06** 
Isolated double bonds, U/ml 
7.31
0.17*
7.67
0.08*/**
7.69
0.07*/**
7.99
0.05*/**
8.15 
0.01*/** 
Diene conjugates, mmol/L 
31.68
1.65*
24.85
0.35*/**
23.44
0.40*/**
22.55
0.34*/**
21.88 
0.23** 
Ketodienes+conjugated trienes, 
U/ml
1.48
0.06*
1.24
0.03**
1.32
0.03*/**
1.25
0.03*/**
1.54 
0.47*/** 
Total hydroperoxides, mmol/L 
78.31
1.33*
75.26
0.31*/**
75.62
0.54*/**
74.48
0.55*/**
73.41 
0.39*/** 
The data presented as mean±SD or percentage 
* – р0.05 versus intact animals, ** – р0.05 versus model of MS  
Table 10. The effect of Vitis Vinifera substances on the plasma HDL composition in male Syrian golden 
hamsters (1 year old) with the experimental MS (in each group n= 10) 
The exact bimolecular mechanisms for this cardioprotection are unclear, but it is likely that 
actions mediated both through the estrogen receptors, such as the beneficial alteration in 
lipid profiles and upregulation of the low-density lipoprotein (LDL) receptor, and 
independently of the estrogen receptors, such as antioxidant action, contribute to the 
cardioprotective effects of phytoestrogens observed. 
The potential role of phytoestrogens, including isoflavonoids, as cardioprotective agents has 
been extensively reviewed. The data obtained in our experiments showed that in male hamsters 
with the experimental MS the treatment with grape extracts reduced VLDL cholesterol (VLDL-
C) and TG by 30 and 40 % compared with the control animals. Furthermore, golden Syrian 
hamsters fed with red wine phenolics had a significant decrease in the plasma apo B 
concentrations. Similar to our previous study, grape polyphenols may have altered hepatic 
secretion of TG-rich VLDL. This reduction is evident when observing the decreases in both 
plasma apo B and apo E concentrations. The significant decrease in apo E concentrations may 
have further reduced plasma TG concentrations. In general, apo E displaces apo C-II from the 
VLDL particle, thereby inhibiting the lipoprotein lipase (LPL) activity and overall lipolysis. 
Furthermore, Huang et al. [51] showed that adding apo C-II to transgenic apo-E3–enriched 
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VLDL increased the LPL activity in a dose-dependent manner. The reductions in apo E and TG 
concentrations suggest less displacement by apo E, thereby promoting the grape polyphenols 
activity and further reducing the TG concentrations in the plasma.  
Due to decreases in TG concentrations, administration of “Cabernet” extract was shown to 
affect the overall lipoprotein metabolism. Decreased concentrations of the plasma TG 
altered substrate availability in the delipidation cascade, leading to the decrease observed in 
LDL-C concentrations. After a 3-week treatment period the grape polyphenols treatment 
induced a significant decrease in the cholesteryl ester transfer protein (CETP) activity as 
well. Such decrease in the CETP activity may be partially a result of the substantial decrease 
in substrate availability, including both the plasma TG and LDL-C.  
It is evident that grape polyphenols modify the packaging of VLDL through alteration in the 
hepatic enzyme activity and apo B secretion. These modifications seem to decrease the 
overall secretion of the VLDL particles and therefore, decrease plasma TG and related apo 
concentrations. Due to decrease of the TG substrate, further modifications in the lipoprotein 
metabolism may occur.  
The alteration in the TG metabolism may not be the single mechanism driving the 
hypocholesterolemic effects of grape polyphenols. When golden Syrian hamsters were 
treated with dealcoholized red wine, red wine, or grape juice, similar significant reductions 
in both TC and LDL-C concentrations were apparent in all treatment groups compared with 
the control [51]. Although there was a trend for decrease in TG concentrations in all 
treatment groups compared with the control, the differences were not significant. That 
study, along with others, suggests the presence of an additional mechanism by which grape 
polyphenols exert the cardioprotective effect. In Hep G-2 cells, dealcoholized red wine was 
shown to upregulate significantly the LDL receptor activity. This significant increase in 
activity was similar to the increase seen when Hep G-2 cells were treated with atorvastatin. 
Furthermore, when Hep G-2 cells were treated with increasing doses of red wine, LDL 
receptor mRNA abundance was significantly increased in a dose-responsive manner. The 
increase of the LDL receptor activity and abundance may be a result of the homeostatic 
intracellular cholesterol feedback loop. In general, decrease in the intracellular cholesterol 
will upregulate the LDL receptor expression and activity, whereas increase in the 
intracellular cholesterol will downregulate the receptor [48]. Grape polyphenols were 
shown to decrease hepatic cholesterol concentrations; therefore, the liver compensates for 
this deficiency by upregulating the LDL receptor and the overall decrease in the plasma 
LDL concentrations occurs.  
One possible explanation of the anti-atherogenic activity of grape polyphenols is the well-
known HDL cholesterol-increasing effect of polyphenols in various species, including 
transgenic mice [52]. 
In our experiments it has been found that the grape extract treatment induced slight (15%) 
increase in HDL cholesterol concentrations is possibly related to the significant decrease in 
the hepatic lipase activity (Table 11). The reductions observed in both hepatic and LPL 
activities by grape polyphenols treatment may prevent formation of small atherogenic 
VLDLB particles and may also decrease their uptake by the LDL receptor -related protein.  
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In addition to increases in HDL cholesterol concentrations, grape extracts also change the 
size and quality of HDL particles [53]. Although the mechanisms by which polyphenols 
influence the metabolism of HDL particles are not clear, changes in LPL and cholesteryl 
ester transfer protein (CETP) may play an important role. 
Polyphenols treatment in humans is associated with decrease in the CETP content correlated 
with the concomitant increase in HDL cholesterol concentrations [54]. Consistent with our 
findings, grape extracts caused a significant increase in the postheparin LPL activity and 
HDL cholesterol concentrations in patients with moderate hypercholesterolemia and in 
hamsters [39]. However, the HDL cholesterol-increasing action of polyphenols in animals 
(mouse, hamster and rat) without CETP in some cases [52] suggests that this effect is may be 
independent of the CETP activity. 
 
milliunits Control (MS) (n=50) Grape extract “Cabernet” (n=50) 
LPL 356.0±53.2 258.6±57.3* 
Hepatic lipase 232.6±25.9 216.2±34.7 
*P<0.05 versus control animals. 
Table 11. The plasma postheparin lipases activity in male hamsters with MS (in each group n=10) 
The “Cabernet” extract appeared to be the most effective substance in relation to the HDL 
defence from peroxidation, though the other substances revealed the same but not so high 
activity. They decreased the content of products (diene conjugates, ketodienes+coupled trienes, 
total hydroperoxides) effectively and increased – substrates (compounds with isolated double 
bonds) of lipoperoxidation, prevented decrease of the antioxidant level (α-tocopherol). 
It should be pointed out that the level of lipid peroxidation secondary products 
(ketodienes+coupled trienes) decreased more effectively under the influence of “Enoant” (to 
intact values). 
Under the action of the studied substances the lipoprotein supply to the liver also decreases, 
evidenced by the decrease of the ApoB-LP content in the organ. Moreover, in the composition 
of these lipoproteins the TAG content normalizes, and it indicates normalization of the activity 
of lipases catalyzing the lipoprotein metabolism in the blood (Table 12). 
The liver oxidative status is also improved: the antioxidant levels almost restore, the 
peroxidation products content decreases, the content of compounds with isolated double 
bonds increases (Tables 3, 5, 9, 12). 
Testing of the “Enoant” action – one of the substances studied – in female hamsters of 
different age with the experimental MS proved the effectiveness of the antioxidant therapy 
of this pathology. 
So, the total lipids, TAG and FFA contents decrease in the blood plasma of those animals 
under the action of “Enoant” (Table 12). In addition, in adult females “Enoant” causes 
decrease in the ApoB-LP and total cholesterol content, and it, in turn, reduces atherogenic 
changes in MS. 
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Parameter 
Group
MS MS +
“Enoant”
MS + 
“Polyphen ”
MS+
“Isabella”
MS+ 
“Cabernet” 
Total cholesterol, % 
of the total ApoB-LP 
composition.
7.180.06* 8.230.26*/** 8.460.05** 8.760.05** 9.100.13** 
TAG, % of the total 
ApoB-LP 
composition
42.001.29* 44.640.52** 44.420.43** 45.950.50** 45.410.73** 
Isolated double 
bonds, U/g 
2.130.06* 2.390.04*/** 2.710.03*/** 2.990.09** 2.770.16** 
Total 
hydroperoxides, 
mmol/g 
101.032.00* 90.551.54*/** 88.691.02*/** 80.460.77*/** 78.832.71*/** 
The data presented as mean±SD or percentage 
* – р0.05 versus intact animals, ** – р0.05 versus the model of MS  
Table 12. The effect of Vitis Vinifera substances on the liver cytosol ApoB-LP composition in male 
Syrian golden hamsters (1 year old) with the experimental MS (in the crude tissue, in each group n= 10) 
The increase of -tocopherol (the main lipid-phase antioxidant) in the blood plasma of 
animals that received “Enoant” proved its antioxidant activity in our experiment (Table 13).  
Furthermore, the significant decrease of the body weight was observed in hamsters that 
received “Enoant” along with a high-calorie diet compared to the animals on a high-calorie 
diet alone. 
Based on these findings, we may conclude that introduction of grape polyphenolic extracts 
and concentrates in MS can prevent the increase of the total lipid and ApoB-LP content in 
the blood plasma, prevent the activation of free radical processes in the plasma lipoprotein 
particles, and normalize the liver lipid metabolism. The ability of the investigated 
substances to reduce negative consequences of MS such as atherosclerosis development has 
been proven. 
The last suggestion is confirmed by our results concerning the aorta wall lipid composition 
in the experimental MS. The introduction of “Enoant” for prophylaxis and treatment 
reduces significantly atherogenesis manifestations in the aorta, decreasing the aorta media 
lipidation and the neutral lipid content (Fig. 3, 4). 
Thus, from our data, we can conclude that antioxidants, particularly grape polyphenolic 
concentrates and extracts, which have pronounced antioxidant, phytoestrogenic and stress-
protector properties, should be included into a complex therapy of MS to reduce its negative 
effects. 
The next experiment was designed to investigate the action of grape wines and polyphenolic 
concentrates on development of proatherogenic effects of the emotional-painful stress. In 
our experiments we used purebred female rats because, as it was shown in previous studies, 
the acute stress response in females was more expressive than in males.  
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Age Group 
Parameter
Total 
lipids, 
mg/ml 
ApoB-
LP, 
mg/ml 
Total 
cholesterol, 
mmol/L 
TAG, 
mg/ml 
FFA, 
mmol/L
Diene 
conjugates 
in ApoB-
LP, 
nmol/ml 
 - 
Tocopherol, 
nmol/ml 
4 
weeks 
MS 
4.52
0.17
4.00
0.16
2.04
0.08
1.08
0.49
1.17
0.06
24.82
1.46
6.67 
0.22 
MS+ 
“Enoant”
3.54
0.16**
3.47
0.13
1.88
0.06
0.91
0.02**
0.95
0.02**
22.27
0.99
9.79 
0.77** 
20 
weeks 
MS 
7.75
0.20
3.84
0.11
2.58
0.07
1.40
0.04
1.42
0.04
23.58
1.35
10.49 
0.82 
MS+ 
“Enoant”
6.88
0.14**
3.30
0.08**
2.22
0.05**
1.18
0.03**
1.15
0.03**
21.10
1.14
12.87 
0.36** 
The data presented as mean±SD or percentage 
** – р0.05 versus the model of MS  
Table 13. The effect of polyphenol concentrate “Enoant” on some plasma lipid metabolism values in 
female Syrian golden hamsters with the experimental MS (in each group n= 10) 
 
Age Group 
Parameters
Total lipids, 
mg/g 
 -
Tocopherol, 
nmol/g
Ascorbic 
acid, 
mkmol/g
TBA active 
substances, 
nmol/g 
4 weeks 
MS 
140.75
9,15
21.01
1.47
3.73
0.14
1.97 
0.06 
MS+
“Enoant” 
111.53
4.08** 
25.31
0.34** 
4.08
0.10 
1.74 
0.09 
20 weeks 
MS 
154.18
2.70 
19.59
0.39 
6.10
0.35 
1.95 
0.09 
MS+
“Enoant”
121.04
4.18**
26.11
1.03**
5.96
0.24
1.73 
0.09 
The data presented as mean±SD or percentage 
** – р0.05 versus the model of MS  
Table 14. The effect of polyphenol concentrate “Enoant” on some liver lipid metabolism values in 
female Syrian golden hamsters with the experimental MS (in each group n= 10) 
During 21 days animals were daily given per os grape wines of “Cabernet” and “Rkatsiteli” 
grades in the doses that corresponded to 300 ml of wine for a human of 70 kg. Other animals 
were given alcohol in the dose corresponding to 30 ml of alcohol for a human of 70 kg, as 
well as polyphenolic concentrates “Enoant” and “Polyphen” in the doses of 0.05 ml/kg of 
the body weight. The grape wines and polyphenolic concentrates were produced by the 
National Institute of Grape and Wine “Magarach”. Control animals were given the 
corresponding volume of the physiological solution. 
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Figure 3. The lipid content in the aorta wall in male Syrian golden hamsters with the experimental MS 
and “Enoant” treatment (Mm, in each group n=10). 
 
 
Figure 4. The lipid content in the aorta wall in female Syrian golden hamsters with the experimental 
MS and “Enoant” treatment (Mm, in each group n=10). 
It was shown that all the substances investigated: polyphenolic concentrates “Enoant” and 
“Polyphen”, 10% solution of ethanol, and grape wines “Cabernet” and “Rkatsiteli” 
possessed the stress-protective activity, which intensity was dependent on the substance 
used (Tables 15-17). 
When introducing only “Enoant” and “Polyphen” to the animals these complexes did not 
cause any changes on the investigated indexes of the pro-oxidant and antioxidant status in 
the liver and it is an indication about safety of using these concentrates. 
“Enoant” and “Polyphen” revealed the significant protective activity in the emotional-
painful stress. It allows to use them as stress-protective, hepatoprotective and 
antiatherogenic remedies. 
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Parameter 
Group
Stress +
Enoant 
Stress +
Polyphen 
Stress +
ethanol 
Stress +
Cabernet 
Stress + 
Rkatsiteli 
str. 
non-
str. 
str. non-str. str. 
non-
str. 
str. 
non-
str. 
str. 
non-
str. 
TL, 
mg/ml 
4.14 
0.45* 
3.98
0.31
**
3.81
0.03
*/**
3.82
0.48 
**
5.50
0.74
*/**
5.58 
0.37*
3.41
0.66
**
3.46
0.43
**
3.43 
0.15 
** 
3.57 
0.54 
** 
TAG, 
mg/ml 
0.76
0.08
*/** 
0.78 
0.09*
0.51 
0.08 
0.71 
0.09* 
0.66
0.12
*/** 
0.91
0.05
*/** 
0.50 
0.05
0.58
0.04
*/** 
0.54 
0.10 
0.54 
0.05 
** 
Total 
cholesterol, 
mg/ml 
70.76 
9.34* 
54.90
6.92
*/**
74.14
8.21*
82.93 
9.48 
**
85.71
5.71
69.10
7.37
**
56.71
7.32*
62.25
6.50
**
97.51 
9.66 
** 
80.83 
8.74 
** 
HDL, mg/ml 
0.98
0.14 
0.89
0.08
0.96
0.05 
0.88
0.08 
1.10
0.19
1.00
0.12
1.26
0.15
1.04
0.08
1.08 
0.12 
0.96 
0.05 
АpоВ-LP, 
mg/ml 
1.56
0.12 
**
1.89 
0.26*
1.59
0.16
** 
1.54
0.22 
**
1.85
0.19
**
1.67
0.18
**
2.07 
0.29*
1.67
0.18
**
1.86 
0.20 
** 
1.63 
0.18 
** 
Corticosterone, 
nmol/l 
5.50
0.99
*/** 
5.87
1.08
*/** 
7.10
0.80
*/** 
29.33 
8.58 
15.00
1.72
*/** 
38.75
5.64
** 
32.75
5.17
** 
26.33
4.40
*/** 
16.93 
2.43 
*/** 
40.60 
6.38 
** 
The data presented as mean±SD 
* - р0.05 versus intact animals 
** - р0.05 versus stressed animals 
Table 15. The effect of grape polyphenol complexes and grape wines on the lipid metabolism and the 
plasma corticosterone level in rats with the neurogenic stress (in each group n=10). 
Moreover, we have found out that the stress-protective activity of grape wines is equal to 
the polyphenolic concentrates activity given in the similar dose. 
Wines of “Cabernet” and “Rkatsiteli” grades normalized the total lipid content both in a 
liver homogenate and in the blood plasma in stress; in addition, TAG levels also reached the 
control values.  
Grape wine components prevented the FFA content increase noted when introducing the 
solution of alcohol. This fact may prove the protective action of the components mediated 
by inhibition of fatty infiltration of organs.  
The latter is confirmed by the absence of influence of grape wine introduction on the 
NADPH-generating dehydrogenases activity in the liver. 
The cholesterol content decrease in the blood plasma when introducing grape wines has 
attracted our attention, as well as a favourable redistribution of cholesterol in the LP 
fractions – decrease of ApoB-containing lipoprotein level with the unchanged HDL content. 
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Parameter 
 
Group
Stress +
Enoant
Stress +
Polyphen
Stress +
ethanol
Stress +
Cabernet
Stress + 
Rkatsiteli 
str. 
non-
str.
str. 
non-
str.
str. 
non-
str.
str. 
non-
str.
str. 
non-
str. 
PON, 
nmol/ml/min 
240.25
20.86
*/** 
216.00
16.24
*/** 
231.33
15.53
*/** 
231.25
15.52
** 
197.50
14.37
*/** 
150.00
19.24
*/** 
239.25
24.18
*/** 
246.00
16.56
** 
222.75 
13.98** 
215.25 
13.78 
** 
Ascorbic acid, 
mkmol/ml 
49.99
4.41*
43.20
4.16*
53.76
4.51
**
45.08
6.08
*/** 
38.04
4.12
*/** 
34.83
4.43*
48.07
2.13*
48.10
2.49
*/** 
55.87 
6.65 
** 
53.41 
5.42 
*/** 
-Tocopherol, 
nmol/ml 
10.70
1.34
**
10.62
0.67
**
10.39
1.12
**
10.8 
1.26
**
6.07 
0.76
*/** 
5.35 
0.78
*/** 
9.45 
1.11
9.99 
0.48
**
10.26 
0.48 
** 
9.32 
1.04 
 
O
x
id
iz
ed
 
Аp
оВ
-L
P
 
Isolated double bonds, 
U/ml 
2.76 
0.36*
2.23 
0.24*
3.14 
0.46
**
3.51 
0.42
*/** 
3.13 
0.37
**
2.35 
0.24*
3.25 
0.38
**
2.64 
0.28*
4.13 
0.43 
** 
3.11 
0.41* 
Diene conjugates, 
mmol/ml 
22.47
3.20
*/** 
25.93
2.98
*/** 
21.54
1.22
*/** 
25.93
1.76
*/** 
30.44
2.20*
26.28
1.24*
23.05
4.48*
26.99
1.38*
19.54 
0.93 
** 
21.56 
0.99 
*/** 
Ketodienes+conjugated 
trienes, U/ml 
2.31 
0.14
 
2.58 
0.29
*/** 
2.20 
0.11
** 
2.37 
0.10*
3.01 
0.50*
2.97 
0.42*
2.29 
0.16
2.60 
0.31*
2.22 
0.11 
 
2.23 
0.06 
** 
The data presented as mean±SD 
* - р0.05 versus intact animals 
** - р0.05 versus stressed animals 
Table 16. The effect of grape polyphenol complexes and grape wines on the plasma 
oxidant/antioxidant status in rats with the neurogenic stress (in each group n=10). 
Paraoxonase activity was normalized in the animals given wines and the antioxidant content 
both in the blood plasma and in the liver was significantly higher than in the control animals. 
These effects together with much lower level of ApoB-LP oxidation in the animals given 
grape wines prove the high antiatherogenic potential of the wines investigated. 
In addition, the grape wines have revealed a rather high level of the stress-protective 
activity and it is indicated by a significant decrease of the corticosterone content in the blood 
plasma in stressed animals given wines. 
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Since grape wines have shown a high level of the stress-protective activity we investigated 
how the ratio of wine components – polyphenols and ethanol – can influence the stress-
protective activity of this complex. 
As was shown in our experiments “Enoant” administration even in the combination with 
ethanol does not reduce the stress-protective action of it, but on the contrary – it intensifies 
this action preventing unfavourable effects of the alcohol. At the same time the TAG and 
FFA level in the liver tissue of rats given ethanol together with “Enoant” decreases even 
when using the lowest dose investigated (0.01 ml per 100 g) (Table 18). Since the content of 
TAG and FFA increases apparently due to the lipogenesis activation when using ethanol, 
which might lead to fatty infiltration of the liver, then reduction of this process activity 
could protect the liver. 
 
Parameter 
 
Group 
Stress + 
Enoant 
Stress + 
Polyphen 
Stress + 
ethanol 
Stress + 
Cabernet 
Stress + 
Rkatsiteli 
str. 
non-
str. 
str. 
non-
str. 
str. 
non-
str. 
str. 
non-
str. 
str. non-str. 
Total 
lipids, 
mg/g 
149.17
33.14
151.84
19.86
** 
130.98
23.66
201.93
33.71
** 
193.32
25.61
*/** 
220.54
23.22
*/** 
171.39
28.66
** 
180.31
15.98
** 
164.93 
16.93 
** 
190.03 
18.21** 
TAG, 
mg/g 
4.65 
0.78 
3.77 
0.47 
6.00 
0.32 
5.94 
1.08
** 
7.86 
0.25
** 
6.89 
0.49
** 
4.90 
1.08 
3.88 
1.08 
5.74 
0.61 
 
4.93 
0.68 
 
АpоВ-LP, 
mg/g 
4.58 
0.06
** 
4.43 
0.07
*/** 
3.72 
0.34*
3.15 
0.44*
5.00 
0.82 
4.10 
0.49
*/** 
3.06 
0.16
*/** 
3.15 
0.16
*/** 
2.87 
0.30 
*/** 
3.02 
0.36* 
FFA, 
mg/g 
1.06 
0.12 
1.00 
0.11
 
1.08 
0.16 
1.26 
0.08*
1.35 
0.15*
1.45 
0.13*
1.05 
0.22 
1.22 
0.20 
1.15 
0.13 
1.40 
0.31 
The data presented as mean±SD 
* - р0.05 versus intact animals 
** - р0.05 versus stressed animals 
Table 17. The effect of grape polyphenol complexes and grape wines on the liver lipid metabolism in 
rats with the neurogenic stress, in the crude tissue (in each group n=10). 
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Parameter 
 
Group 
Stress +
Enoant
Stress +
Polyphen
Stress +
ethanol
Stress +
Cabernet
Stress + 
Rkatsiteli 
str. non-str. str. non-str. str. 
non-
str.
str. 
non-
str.
str. non-str. 
GSH, 
mkmol/g 
6.02 
0.27
*/**
3.70 
0.42* 
5.12 
0.46 
5.48 
0.34 4.40 0.34
2.87 
0.29
*/** 
4.64 
0.70
4.38 
0.35
4.47 
0.51 
3.59 
0.50* 
-Тocopherol, 
nmol/g 
27.82
2.86
*/** 
34.01 
3.56 
**
34.34 
4.14 
**
25.39 
1.18
*/** 
6.55 
0.61
*/** 
5.59 
0.54
*/** 
26.95
1.32
*/** 
24.64
0.81
*/** 
29.24 
1.82 
*/** 
28.9 
3.15 
** 
Ascorbic acid, 
mkmol/g 
1.31 
0.13
**
1.29 
0.10
*/** 
1.17 
0.23* 
1.25 
0.15
*/** 
0.59 
0.07
*/**
0.81 
0.06*
1.04 
0.21*
1.21 
0.11
*/** 
1.24 
0.20 
*/** 
1.24 
0.17 
*/** 
Isolated double 
bonds, U/g 
18.63
1.88
*/**
15.99 
1.50
*/**
20.40 
1.34
*/**
18.66 
1.52
*/**
16.98
0.66*
13.89
1.73*
24.40
2.92
*/**
16.15
1.76
*/**
26.67 
1.62 
*/** 
18.82 
1.90 
*/** 
Diene conjugates, 
mmol/g 
13.58
0.74
*/** 
12.87 
0.54
*/** 
13.48 
0.62
*/** 
12.85 
0.26
*/** 
13.61
0.08
*/** 
13.20
0.58
*/** 
10.90
1.10
**
15.00
2.12*
10.66 
1.88 
** 
14.32 
1.62* 
Ketodienes+conju
gated trienes, U/g
13.57
0.54*
13.39 
1.67 
11.44 
1.56 
**
11.84 
1.88
*/** 
12.68
1.91
13.04
1.31
**
14.20
2.02*
15.74
1.98
17.15 
1.62* 
16.04 
1.78 
ТBA-active 
products, 
nmol/mg protein
0.21 
0.02*
0.19 
0.02 
**
0.28 
0.03* 
0.22 
0.03 
**
0.55 
0.08
*/** 
0.68 
0.06
*/** 
0.15 
0.02
0.28 
0.04*
0.18 
0.02 
0.17 
0.02 
** 
The data presented as mean±SD 
* - р0.05 versus intact animals 
** - р0.05 versus stressed animals 
Table 18. The effect of grape polyphenol complexes and grape wines on the liver tissue 
oxidant/antioxidant status in rats with the neurogenic stress (in the crude tissue, in each group n=10). 
It should be noted that the effect of high doses of “Enoant” (0.1 and 0.15 ml/100 g) was 
ambiguous. On the one hand, it caused α-tocopherol accumulation in the liver that might be 
an indicator of their protective action, but on the other hand, it probably revealed some 
 
Lipoproteins – Role in Health and Diseases 474 
prooxidative effect initiating the increase in the content of the POL final products – 
thiobarbituric acid-active products, and also activating ApoB-containing lipoproteins 
oxidation. In this case the secondary oxidative stress developed. A tendency to decrease the 
lipid content in the liver and to increase it in the blood plasma testifies about it. 
Such effect is typical for high doses of many antioxidants capable to reveal the prooxidant 
action, including α-tocopherol. These data indicate the necessity of reasonable attitude to 
antioxidants therapy, including “Enoant”. 
 
Parameter 
Group 
Stress 
+Ethanol
Stress+Ethanol+ Enoant, ml per 100 g of the body weight: 
0.01 0.03 0.05 0.07 0.1 0.15 
Total lipids, 
mg/ml 
5.89 
0.08* 
5.69 
0.06* 
5.30 
0.05* 
4.82 
0.15* 
3.51 
0.08 
3.44 
0.09 
3.58 
0.15 
TAG, mg/ml 
0.91 
0.07* 
0.99 
0.04* 
0.73 
0.04* 
0.52 
0.03 
0.43 
0.03 
0.39 
0.02* 
0.50 
0.02 
Total 
cholesterol, 
mg/ml 
0.49 
0.07 
0.46 
0.05 
0.54 
0.04 
0.40 
0.01* 
0.55 
0.09 
0.55 
0.03 
0.56 
0.02 
HDL, mg/ml 
0.93 
0.02 
1.00 
0.06 
1.02 
0.07 
0.91 
0.05 
1.81 
0.03* 
1.23 
0.06* 
1.32 
0.04* 
АpоВ-LP, 
mg/ml 
1.73 
0.05* 
1.84 
0.05* 
1.48 
0.06 
1.44 
0.03 
1.18 
0.05 
1.41 
0.02 
1.64 
0.04* 
-Тocopherol, 
nmol/мml 
4.11 
0.34* 
4.88 
0.17* 
5.84 
0.14* 
6.68 
0.24* 
8.20 
0.34* 
9.23 
0.35 
8.80 
0.46 
Ascorbic acid, 
mkmol/L 
33.81
1.73* 
34.04 
2.73* 
39.04 
1.60* 
49.25 
1.10* 
55.01 
1.67 
56.98 
2.03 
49.96 
3.43 
Diene 
conjugates in 
АpоВ-LP, 
mkmol/L 
28.11
0.34* 
28.99 
0.14* 
29.35 
0.80* 
28.81 
1.30* 
23.91 
0.51 
20.60 
1.43 
28,27 
1.35* 
ТBA-active 
products, 
mkmol/L 
2.39 
0.55* 
2.01 
0.30* 
1.48 
0.16* 
1.11 
0.04 
1.18 
0.34 
0.77 
0.21 
1.31 
0.20* 
Corticosterone, 
nmol/L 
35.25
4.27 
24.00 
3.03 
28.25 
4.54 
16.00 
0.44* 
25.50 
0.50 
17.50 
2.33* 
21.60 
6.00 
The data presented as mean±SD 
* - р0.05 versus intact animals 
Table 19. The effect of different doses of polyphenol concentrate “Enoant” in combination with ethanol 
on the plasma parameters of the stress response development in rats with the neurogenic stress (in each 
group n=10). 
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At the same time small doses of “Enoant” have a relatively low biological activity; they do not 
reduce negative effects of ethanol intake and do not inhibit the stress response significantly. 
Therefore, we can conclude that the most effective doses of “Enoant” are 0.05-0.07 ml/100 g 
of the body weight because with these doses “Enoant” has not only high stress-protective, 
antiatherogenic and hepatoprotective activities, but practically neutralizes negative effects 
of ethanol. 
Thus, our results suggest that grape wines have a high stress-protective, antiatherogenic and 
hepatoprotective activity that is equal to grape polyphenolic non-alcoholic concentrates 
characteristics, and the wine components in the doses studied have prevented negative 
effects of ethanol. Introduction of ethanol to animals in the human equivalent dose – 0.43 
ml/kg of the body weight increases their tolerance to stress, but is an unfavourable factor 
that could result in MS development, fatty infiltration of organs and other pathologies. The 
polyphenolic concentrates “Enoant” and “Polyphen” in the human equivalent dose – 0.3 
ml/kg of the body weight reveal a significant stress-protective, hepatoprotective and anti-
atherogenic activity under the action of the emotional-painful stress. Grape wines from 
“Cabernet” and “Rkatsiteli” grades in the human equivalent dose – 4.3 ml/kg of the body 
weight also reveal a high stress-protective, antiatherogenic and hepatoprotective activity 
equal to grape polyphenolic non-alcoholic concentrates, and the wine components in the 
doses used prevented the negative effect of ethanol. 
The highest activity has been shown by the combination of “Enoant” and ethanol that 
corresponds to the ratio of components in dry red wines, as well as the absence of significant 
difference in the protective effects of red and white wines, in spite of the difference in the 
polyphenol content [55]. Based on these results, in the second series of our experiments we 
decided to investigate “Cabernet” and “Rkatsiteli” wine effects on the development of 
stress-reaction proatherogenic consequences under the action of the emotional-painful stress 
in different periods of introduction. 
It has been shown that “Cabernet” had a higher level of the anti-atherogenic activity than 
“Rkatsiteli”; in relation to the stress-protective activity the wines of these grades did not 
differ markedly. Such effect is likely connected with accumulation of polyphenols in the 
organism. 
To examine the last supposition it was necessary to determine how different periods of 
introduction of the investigated wines influenced the stress-reaction development. We have 
carried out the study of wine intake influence on the development of proatherogenic 
consequences of the emotional and painful stress in different terms after consumption. 
The data obtained in the experiments showed significant improvement of the antioxidant 
status both in the blood plasma and the liver tissue one day after the introduction of 
“Cabernet” wine (tables 20, 21).  
At the same time “Rkatsiteli” wine did not reveal such activity. A similar condition 
persisted for 2-5 days of administration. 
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Periods of 
time 
Parameter 
Total lipids, 
mg/g 
TAG, mg/g
GSH, 
mkmol/g 
-
Tocopherol, 
nmol/g 
Diene 
conjugates, 
nmol/g 
ТBA-active 
products, 
nmol/g 
Day 
1 
C+Str 94.945.65* 3.800.11* 2.120.17* 18.880.79* 14.930.37* 1.680.10 
R+Str 103.164.63* 5.150.61* 2.370.28* 15.600.39* 15.940.39* 2.240.32 
Day 
2 
C+Str 105.175.12* 3.580.23* 2.510.34* 26.042.17* 14.130.09* 1.070.24* 
R+Str 106.939.42* 5.670.34* 2.770.87* 15.650.92* 15.100.07* 1.910.15 
Day 
3 
C+Str 115.3811.65* 3.920.13* 3.820.37* 23.692.18* 13.850.48* 1.700.11 
R+Str 103.285.81* 6.470.28* 2.470.26* 16.890.71* 14.440.25* 2.290.20* 
Day 
5 
C+Str 139.148.06* 5.570.31* 2.430.37* 26.962.12 13.190.34 1.350.15 
R+Str 116.663.60* 6.880.37* 2.430.42* 18.641.18* 14.220.16* 2.060.13 
Day 
8 
C+Str 161.186.05* 7.270.15 4.110.21 32.120.85 12.280.52 1.640.13 
R+Str 122.207.07* 6.350.45 2.330.28* 23.082.08* 12.930.44 1.730.04 
Day 
10 
C+Str 181.829.24 8.040.63 5.150.42 30.622.53 11.860.12 1.300.19* 
R+Str 153.995.30* 8.410.56 3.220.48* 26.311.26* 11.840.48 1.290.14* 
Day 
12 
C+Str 174.726.15 8.340.55 3.740.25 32.555.58 12.420.36 1.470.27 
R+Str 164.48.03* 8.630.47 3.250.17* 28.282.26 11.410.22 1.450.31 
Day 
15 
C+Str 162.1612.81 7.500.43 4.610.22 38.162.06* 10.500.52* 1.340.06* 
R+Str 172.1310.42 7.680.69 4.420.34 41.992.42 10.270.63* 1.240.17 
The data presented as mean±SD 
* - р0.05 versus intact animals 
Table 20. The effect of prophylactic administration of grape wines of "Cabernet" (C) and "Rkatsiteli" (R) 
grades on the stress response development in the liver tissue in rats with the neurogenic stress in 
different periods of time, in the crude tissue (in each group n=10). 
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Periods of 
time 
Parameter 
Total 
lipids, 
mg/ml 
TAG, 
mg/ml 
Total 
cholesterol, 
mg/ml 
АpоВ-LP, 
mg/ml 
-
Тocopherol, 
nmol/ml 
Diene 
conjugates, 
nmol/ml 
Corticosterone 
nmol/l 
Day 
1  
 
C+Str 5.15±0.50* 0.78±0.07* 0.94±0.04 1.53±0.02* 8.52±0.27* 31.49±2.58* 75.00±8.66* 
R+Str 6.15±0.44* 0.93±0.07* 1.08±0.05# 1.68±0.03* 6.29±0.47* 38.35±1.56* 111.70±10.00 
Day 
2 
C+Str 3.87±0.23 0.71±0.04* 0.89±0.03 1.52±0.02* 8.90±0.72* 31.65±1.92* 96.6721.86* 
R+Str 4.85±0.16* 0.84±0.06* 0.86±0.04 1.70±0.04* 7.77±0.27 32.17±1.71* 81.5416.50* 
Day 
3 
C+Str 3.42±0.32 0.56±0.03 0.73±0.05* 1.54±0.04* 10.20±0.52 24.72±2.89 35.679.49 
R+Str 4.45±0.41 0.70±0.04* 0.89±0.06 1.66±0.04* 8.49±0.38* 22.24±1.84 43.008.50 
Day 
5 
C+Str 3.54±0.27 0.49±0.05 0.72±0.02* 1.45±0.06 10.28±0.65 28.34±1.77* 41.5018.50 
R+Str 3.56±0.23 0.58±0.05 0.88±0.02 1.66±0.04* 10.01±0.27 20.46±2.03 57.103.00* 
Day 
8 
C+Str 3.47±0.39 0.49±0.08 0.77±0.02* 1.36±0.03 12.02±0.35 20.47±2.03 42.5010.61 
R+Str 4.08±0.31 0.4±0.06 0.84±0.03 1.55±0.04 10.04±0.68 20.15±2.61 40.509.19 
Day 
10 
C+Str 3.73±0.24 0.54±0.05 0.69±0.02* 1.33±0.02 11.03±0.89 22.68±2.46 34.0018.38 
R+Str 3.60±0.35 0.55±0.09 0.76±0.04* 1.43±0.04 11.39±0.47 22.90±1.93 38.002.82 
Day 
12 
C+Str 3.71±0.35 0.49±0.07 0.65±0.03* 1.26±0.04 11.18±1.01 21.72±1.57 25.502.12 
R+Str 3.55±0.45 0.054±0.06 0.75±0.03* 1.35±0.03 11.40±0.93 20.08±1.45 27.001.31 
Day 
15 
C+Str 3.78±0.36 0.59±0.04 0.61±0.02* 1.33±0.02 11.04±1.32 20.99±0.92 34.007.00 
R+Str 4.22±0.57 0.51±0.09 0.69±0.03* 1.29±0.06 11.72±0.93 20.59±1.92 31.0010.82 
The data presented as mean±SD 
* - р0.05 versus intact animals 
Table 21. The effect of prophylactic administration of grape wines of "Cabernet" (C) and "Rkatsiteli" (R) 
grades on the plasma parameters of the stress response development in rats with the neurogenic stress 
(in each group n=10). 
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However, on day 8 of administration the antioxidant and stress-protective effects of these 
wines were almost similar, and on the day 10 –they practically did not differ. 
On days 12 and 15 there were also no differences as to the antioxidant and stress-protective 
action of the wines studied, which significantly reduced activation of the free radical 
oxidation under the action of stress normalizing the most of the indexes investigated. 
Thus, the investigated wines are characterized by the high level of the antioxidant and 
stress-protective activity, and in the first days of introduction “Cabernet” wine improved 
more effectively the antioxidant status in the blood and the liver tissue than “Rkatsiteli” 
wine, but by day 10 the effects of the studied wines had no substantial difference. 
Probably, these results are dependent on polyphenol cumulation in the organism because it 
is known that the polyphenol content of “Cabernet” is 10 times more than of “Rkatsiteli”. 
Thus, the results suggest that “Cabernet” and “Rkatsiteli” wines have already revealed the 
high stress-protective, hepatoprotective and anti-atherogenic activity in the conditions of the 
emotional-painful stress on the 2-3 days after introduction, and practically normalized the 
oxidative status and the lipid metabolism under the action of stress in prophylactic 
administration within 10 days. This indicates that grape polyphenols possess a high total 
antioxidant activity. At the same time the last suggestion required further research. 
In order to examine the effects of wine stocks and polyphenolic concentrates obtained from 
other grape grades on development of proatherogenic consequences of the emotional-
painful stress we investigated the action of substances obtained from the grapes of hybrid 
grades “Krasen”, “Golubok” and “Podarok Magaracha” produced by the National Institute 
of Grape and Wine “Magarach”. 
In the series of experiments we used purebred male rats that during 21 day were given daily, 
per os, table wine stocks of the grades “Podarok Magaracha”, “Krasen” and “Golubok” in the 
human equivalent dose corresponding to 300 ml of wine for a human with 70 kg of the body 
weight. Other groups of animals were given ethanol in the human equivalent dose 
corresponding to 30 ml of ethanol for a human with 70 kg of the body weight taking into 
account the species sensitivity coefficients, as well as the table wine stocks of the grades 
mentioned in doses equivalent to the polyphenol content of the given wines calculated by the 
polyphenol content in active doses (AD – 9 mg of polyphenols/100 g of the body weight). 
The results have demonstrated that not only polyphenolic concentrates, but the table wine 
stocks also revealed a substantial stress-protective activity to a different extent (Tables 22-25). 
In fact, “Krasen” table wine stock revealed the highest activity; the stress-protective activity 
was almost 2.4 times more the ethanol activity in the dose studied. This product effectively 
prevented the activation of free radical oxidation both in the blood (increased the level of 
compounds with isolated double bonds in the atherogenic ApoB-LP, decreased the content 
of peroxidation products – diene conjugates – almost 3 times comparing to the stressed 
animals, and 15% - comparing to the intact animals), and the liver tissue (prevented the 
antioxidant content decrease, particularly the content of -tocopherol and ascorbic acid 
returned practically to the intact level, and there was 40% decrease of the diene conjugates 
level). At the same time this table wine stock prevented hyperlipidemia and the shift of 
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metabolism to the increased lipolysis, there was 60% decrease of the blood total lipid content 
comparing to the stressed animals, and 11% - comparing with the intact animals. At the same 
time the TAG content in the liver was equal to the intact level that also demonstrated the 
protective action of this table wine stock. Reduction of lipogenesis in the liver tissue under the 
action of this product is important, and it protects the organ from steatosis. It should be also 
mentioned that the given product normalized the cholesterol content in the blood plasma.  
 
Group 
Parameter
Total lipids, 
mg/g 
TAG, mg/g 
FFA, 
mmol/g 
АpоВ-LP, 
mg/g 
Lysosomal 
lipase,  
nmol/mg 
protein/min 
Str.+Con. 
Podarok 
Magaracha (AD)
149.03 
2.59*,** 
5.74 
0.07** 
4.46 
0.04* 
4.22 
0.03*,** 
0.45 
0.03** 
Str.+Con. 
Krasen (АD) 
147.13
1.15*
4.27
0.02*,**
4.19
0.05*,**
4.61
0.01*,**
0.50 
0.02 
Srt.+Wine 
Podarok 
Magaracha 
161.74 
1.91*,** 
6.33 
0.05** 
4.30 
0.11*,** 
4.43 
0.03*,** 
0.32 
0.01*,** 
Srt.+Wine 
Krasen 
155.88
1.35*,** 
6.04
0.16** 
3.24
0.04** 
4.50
0.07*,** 
0.56 
0.03** 
Str.+Con. 
Podarok 
Magaracha (DW)
141.29 
1.79* 
4.95 
0.15*,** 
3.83 
0.09** 
3.18 
0.03* 
0.65 
0.02** 
Str.+Con. 
Krasen (DW) 
145.87
3.19* 
4.24
0.07*,** 
4.23
0.07*,** 
4.39
0.08*,** 
0.55 
0.03** 
Wine 
Podarok 
Magaracha 
182.4 
3.08* 
6.51 
0.07** 
2.70 
0.08*,** 
4.80 
0.10*,** 
0.37 
0.01* 
Wine 
Krasen 
164.36
1.86 
5.97
0.17 
2.95
0.09* 
4.93
0.18* 
0.35 
0.02* 
Con. 
Podarok 
Magaracha (AD)
191.33 
2.03* 
6.47 
0.04* 
4.61 
0.31* 
4.33 
0.08* 
0.83 
0.03* 
Con. 
Krasen (AD) 
170.4
2.09 
6.15
0.14 
3.22
0.05 
4.97
0.11* 
0.69 
0.02# 
Ethanol 
229.76
3.39*
7.40
0.13*
4.57
0.13*
6.11
0.07*
0.38 
0.02* 
The data presented as mean±SD 
* - р0.05 versus intact animals 
** - р0.05 versus stressed animals 
Table 22. The effect of grape polyphenol concentrates and grape wines on the liver lipid metabolism in 
rats with the neurogenic stress (in the crude tissue, in each group n=10). 
 
Lipoproteins – Role in Health and Diseases 480 
It is also necessary to point out that the control intake of the investigated substances (Tables 
22-25) did not reveal negative effects on the organisms of the experimental animals. 
Moreover, in addition to the antioxidant activity these substances revealed a significant 
hypocholesterolemic and anti-atherogenic action, which was more pronounced when using 
“Krasen” grade wine stock and the concentrate. 
 
Group 
Parameter
GSH, 
mkmol/g 
-Тocopherol,
nmol/g 
Ascorbic acid, 
mkmol/g 
Diene 
conjugates, 
nmol/g 
ТBA-active 
products, nmol/ 
mg protein 
Str.+Con. 
Podarok 
Magaracha (AD)
3.34 
0.02*,** 
24.01 
0.47*,** 
1.21 
0.01*,** 
14.96 
0.22*,** 
0.49 
0,01 
Str.+Con. 
Krasen (АD) 
3.8
0.02*,** 
26.71
0.46*,** 
1.28
0.01*,** 
15.03
0.11*,** 
0,45 
0.02 
Srt.+Wine 
Podarok 
Magaracha 
3.48 
0.02*,** 
26.71 
0.34*,** 
1.33 
0.02*,** 
13.81 
0.18#,** 
0.42 
0.03** 
Srt.+Wine 
Krasen 
3.57
0.08*,** 
28.46
0.75** 
1.41
0.03*,** 
13.36
0.40** 
0.21 
0.01*,** 
Str.+Con. 
Podarok 
Magaracha 
(DW) 
2.00 
0.07*,** 
21.72 
0.51*,** 
1.02 
0.03*,** 
16.05 
0.11*,## 
 
0.47 
0.01 
Str.+Con. 
Krasen (DW) 
3.27
0.06* 
21.12
0.39*,** 
1.04
0.03*,** 
16.72
0.16*,## 
0.45 
0.02 
Wine 
Podarok 
Magaracha 
4.68 
0.10*,** 
33.59 
0.60 
2.16 
0.04* 
10.42 
0.53* 
0.15 
0.01* 
Wine 
Krasen 
4.56
0.24 
35.48
0.78* 
1.57
0.03 
9.27
0.24* 
0.13 
0.01* 
Con. 
Podarok 
Magaracha (AD)
4.46 
0.13 
35.29 
0.45* 
1.95 
0.03* 
10.87 
0.41 
0.20 
0.01* 
Con. 
Krasen (AD) 
4.82
0.14* 
27.84
0.39 
2.00
0.04* 
10.26
0.06* 
0.15 
0.01* 
Ethanol 
5.31
0.35* 
24.16
1.40* 
2.06
0.03* 
12.62
0.60 
0.46 
0.02 
The data presented as mean±SD 
* - р0.05 versus intact animals 
** - р0.05 versus stressed animals 
Table 23. The effect of grape polyphenol concentrates and grape wines on the oxidant/antioxidant 
status in the liver tissue in rats with the neurogenic stress (in the crude tissue, in each group n=10). 
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Group 
Parameter  
Total 
lipides, 
mg/ml 
TAG, 
g/ml 
FFA, 
mmol/L 
Total 
cholesterol, 
g/ml 
HDL, 
mg/ml 
АpоВ-LP, 
mg/ml 
Cortico-
sterone, 
nmol/L 
Str.+Con. 
Podarok 
Magaracha 
(AD) 
3.89 
0.08** 
0.72 
0.01*,**
1.40 
0.02#,**
56.66 
1.49*,** 
0.79 
0.02*,** 
1.45 
0.05*,** 
47 
2** 
Str.+Con. 
Krasen (АD) 
4.12 
0.08# 
0.67 
0.01*,**
1.16 
0.03*,**
58.70 
1.77 
0.82 
0.03 
0.,90 
0.04*,** 
47 
3** 
Srt.+Wine 
Podarok 
Magaracha 
4.60 
0.11* 
0.65 
0.02*,**
1.63 
0.02* 
63.32 
1.01** 
0.85 
0.02** 
1.21 
0.02** 
41 
1*,** 
Srt.+Wine 
Krasen 
3.42 
0.09*,**
0.52 
0.03** 
1.40 
0.04** 
64.69 
1,70** 
0.86 
0.02 
1.08 
0.03#,** 
42 
1** 
Str.+Con. 
Podarok 
Magaracha 
(DW) 
5.25 
0.07* 
0.74 
0.02* 
0.74 
0.02*,**
56.67 
1.15*,** 
0.87 
0.03 
1.75 
0.07*,** 
60 
2 
Str.+Con. 
Krasen (DW) 
3.88 
0.08** 
0.67 
0.01*,**
0.67 
0.01*,**
55.58 
1.21*,** 
0.83 
0.03** 
1.06 
0.03*,** 
63 
1* 
Wine 
Podarok 
Magaracha 
3.72 
0.09 
0.38 
0.01* 
1.14 
0.02* 
60.78 
1.64 
1.4 
0.02* 
1.11 
0.02 
54 
2 
Wine 
Krasen 
3.76 
0.03 
0.36 
0.01* 
1.18 
0.02* 
57.21 
0.81# 
1.11 
0.02* 
1.14 
0.01 
44 
4 
Con. 
Podarok 
Magaracha 
(AD) 
4.32 
0.04* 
0.56 
0.02 
1.23 
0.01 
68.70 
1.22 
1.04 
0.02* 
1.14 
0.02 
71 
2* 
Con. 
Krasen (AD) 
3.78 
0.04 
0.39 
0.02* 
1.43 
0.04* 
60.89 
1.67 
1.16 
0.02* 
1.20 
0.02 
35 
2* 
Ethanol 
4.05 
0.09 
0.74 
0.03* 
1.65 
0.02* 
55.80 
1.46* 
1.24 
0.06* 
1.32 
0.02* 
75 
3* 
The data presented as mean±SD 
* - р0.05 versus intact animals 
** - р0.05 versus stressed animals 
Table 24. The effect of grape polyphenol concentrates and grape wines on the plasma lipid metabolism 
parameters and corticosterone level in rats with the neurogenic stress (in each group n=10). 
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Group 
Parameter 
PON, nmol/
mlmin 
Ascorbic acid, 
mkmol/L 
-Тocopherol, 
nmol/ml 
Isolated 
double bonds 
in ApоВ-LP 
Diene 
conjugates in 
ApоВ-LP 
Str.+Con. 
Podarok 
Magaracha 
(AD) 
174 
2* 
37.26 
1.60*,** 
7.77 
0.21* 
2.07 
0.09* 
27.03 
1.30*,# 
Str.+Con. 
Krasen (АD) 
194 
3*,** 
41.79 
0.44*,** 
8.25 
0.66*,** 
2.35 
0.15* 
26.86 
0.43* 
Srt.+Wine 
Podarok 
Magaracha 
173 
3* 
40.08 
1.72*,** 
8.91 
0.29** 
1.92 
0.25* 
18.45 
0.18*,** 
Srt.+Wine 
Krasen 
189 
2*,** 
54.30 
0.97*,** 
10.42 
0.16*,** 
2.47 
0.03*,** 
14.50 
0.35*,** 
Str.+Con. 
Podarok 
Magaracha 
(DW) 
159 
1* 
35.46 
1.10* 
7.04 
0.07* 
1.52 
0.06* 
25.73 
0.68*,** 
Str.+Con. 
Krasen (DW) 
179 
2*,** 
48.59 
0.96*,** 
8.03 
0.06*,** 
2.21 
0.07* 
27.68 
0.60*,** 
Wine 
Podarok 
Magaracha 
223 
6 
75.95 
0.74* 
10.03 
1.72 
5.43 
0.12* 
15.67 
0.15* 
Wine 
Krasen 
215 
3* 
74.79 
0.34* 
11.52 
0.24* 
5.55 
0.15* 
15.81 
0.15* 
Con. 
Podarok 
Magaracha 
(AD) 
221 
4 
67.04 
1.40 
9.49 
0.24 
4.83 
0.11 
16.87 
0.21 
Con. 
Krasen (AD) 
255 
3 
70.61 
2.31 
9.97 
0.16 
5.39 
0.04* 
15.47 
0.34* 
Ethanol 
236 
3 
79.49 
2.18* 
10.22 
0.36 
5.75 
0.17* 
17.82 
0.24 
The data presented as mean±SD 
* - р0.05 versus intact animals 
** - р0.05 versus stressed animals 
Table 25. The effect of grape polyphenol concentrates and grape wines on the plasma 
oxidant/antioxidant status in rats with the emotional-painful stress (in each group n=10). 
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5. Conclusion 
Based on our findings, it is possible to state that antioxidant complexes, particularly 
polyphenol extracts and the concentrates obtained from Vitis Vinifera, which are safe and 
reveal the potent antioxidant and stress-protective activity, should be used for reduction of 
proaterogenic states consequences in the complex prophylactic and treatment of 
atherosclerosis as effective stress-protective remedies. 
Thus, administration of Vitis Vinifera substances can prevent the increase of the total 
lipoprotein and ApoB-LP content in the blood, and prevent the free radical process 
activation in the plasma lipoprotein particles, and, in general, normalize the lipid and 
lipoprotein metabolism in the liver in metabolic syndrome. These results have proven the 
ability of the investigated complexes to reduce such negative consequence of metabolic 
syndrome as development of atherosclerosis. 
In addition, according to obtained research data the polyphenolic concentrates possess a 
potent protective activity both in acute and chronical neurogenic stress. 
Our studies suggest that multicomponent active substances with antioxidant properties are 
more effective in correction of the proatherogenic states caused by stress and metabolic 
syndrome negative effects in comparison with individual antioxidants (particularly, α-
tocopherol). The research data suggest that the increased plasma antioxidant activity alone 
does not result in decreased foam cell formation, at least in the studied animal model. 
Moreover, in vitro studies have shown that α-tocopherol can be pro-oxidative rather than 
protective for lipids in isolated LDL. Similarly with vitamin E, vitamin C additives do not 
offer consistent benefit against atherosclerosis in animals.  
The occurrence of tocopherol-mediated peroxidation and the mode of its prevention 
predicts that the balance of α-tocopherol and available coantioxidants, rather than α-
tocopherol alone, determines whether LDL lipid peroxidation occurs in biological systems. 
Inhibition of the free radical process with the polyphenolic complexes administration can be 
associated with their ability to increase the level of antioxidants – α-tocopherol, ascorbic 
acid and reduced glutathione in the test animal liver tissue compared with the group of the 
stressed animals. The complexes obtained from Vitis Vinifera, in particular, polyphenolic 
concentrates “Enoant” and “Polyphen”, as well as grape wines (particularly “Cabernet”) 
with their moderate use revealed the potent antioxidant activity. The preliminary results 
also suggest that coantioxidants inhibit lipoprotein lipid peroxidation in vivo. Thus, if LDL 
oxidation causes atherosclerosis, the requirement for coantioxidants may explain why 
supplementation with individual antioxidants, particular vitamin E alone, overall has 
yielded inconclusive results in the controlled human and animal intervention studies. 
In conclusion, our research results may be used for the development of the atherosclerosis 
prophylaxis strategy, and treatment of diabetes mellitus and metabolic syndrome because 
recent studies proved insufficient effectiveness of α-tocopherol and advantages of 
multicomponent antioxidant complexes administration. The high effectiveness of the 
polyphenolic complexes obtained from Vitis Vinifera, including polyphenolic concentrates 
 
Lipoproteins – Role in Health and Diseases 484 
“Enoant” (from grape of “Cabernet” grade) and “Polyphen” (from grape of “Rkatsiteli” 
grade) produced by the National Institute of Grape and Wine “Magarach” has been proven. 
Our results also confirmed the high effectiveness of the antioxidant complexes from grapes 
in the correction of the endothelial dysfunction, thus, including these extracts in the 
treatment schemes is very reasonable. As it would be expected from our observations, 
increasing the antioxidant oxidant defense by antioxidant supplementation has the ability to 
restore the endothelial vasomotor function. 
An important question to be asked is whether the polyphenol antioxidants exerted their 
inhibitory effect on lesion progression only because of their antioxidant properties or, possibly, 
because of additional biological properties, in particular – the phytoestrogen activity. 
However, further studies, especially in humans, are required to validate the role of these 
antioxidants in inhibiting LDL oxidation. 
Nevertheless, there are some limitations in the use of the concentrates produced from red 
grade grapes because of the uric acid content changes. 
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